Yanski personal page - To The Moon

Yanski

Yanski

No personal profile

327Follow

15Followers

0Topic

0Badge

2021-03-12

[666]

Warren Buffett is now worth $100 billion

2021-03-08

Really? ?

AMC Entertainment Holdings Inc. once surged 9%

2021-03-02

Good news! ☺️

S&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap

2021-02-22

Good news! ☺️

Vietnam to start COVID-19 vaccinations in March -state media

2021-02-21

Good news!

S.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says

2021-02-20

Good news!

New Zealand begins COVID-19 vaccinations programme, Australia starts Monday

2021-02-18

Good read!

Singapore Exchange hopes to list SPACs as early as this year

2021-02-18

Wow good news.

PayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.

2021-02-17

Is this the reason why apple numbers is decreasing?

Apple iCar Speculation Continues. How Tech and Auto Analysts See the Car.

2021-02-16

Cool

With Biden going big, Wall Street economists are growing bullish on the US economy

2021-02-16

Nice to know

With Biden going big, Wall Street economists are growing bullish on the US economy

2021-02-15

Good to know and hope everyone in the world will be vaccinated.

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

2021-02-14

Better wait for safe vaccine than sorry. ?

Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3575171209981735,"uuid":"3575171209981735","gmtCreate":1612096597582,"gmtModify":1613702920593,"name":"Yanski","pinyin":"yanski","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":327,"tweetSize":120,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.95%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":328150862,"gmtCreate":1615508192156,"gmtModify":1704783777345,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"[666]&nbsp;","listText":"[666]&nbsp;","text":"[666]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328150862","repostId":"1119544264","repostType":4,"repost":{"id":"1119544264","pubTimestamp":1615476407,"share":"https://ttm.financial/m/news/1119544264?lang=&edition=fundamental","pubTime":"2021-03-11 23:26","market":"us","language":"en","title":"Warren Buffett is now worth $100 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1119544264","media":"CNN Business","summary":"New York/Hong Kong  - Warren Buffett has just joined the world's most exclusive club of the mega rich.The legendary American investor was worth $100 billion on Thursday, according to the Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebookCEO Mark Zuckerberg.The 90-year-old Buffett has added nearly $13 billion to his net worth this year as shares in his industrial a","content":"<p><b>New York/Hong Kong (CNN Business)&nbsp;-&nbsp;</b>Warren Buffett has just joined the world's most exclusive club of the mega rich.</p>\n<p>The legendary American investor was worth $100 billion on Thursday, according to the&nbsp;Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebook(FB)CEO Mark&nbsp;Zuckerberg.</p>\n<p>The 90-year-old&nbsp;Buffett&nbsp;has added nearly $13 billion to his net worth this year as shares in his industrial and insurance conglomerate have surged.Berkshire Hathaway(BRKA)is up nearly 15% in 2021, giving the company a market capitalization of more than $600 billion.</p>\n<p>Buffett and Berkshire Hathaway are famous for investing primarily in slow growth, \"value\" stocks — many of which have done very well this year as markets continue to recover from the pandemic-fueled crash a year ago. He recently revealed that Berkshire&nbsp;bought stakes in Dow components&nbsp;Chevron and Verizon, indicating a new interest in Big Oil, telecom and media.</p>\n<p>Chevron(CVX)is up 31% as&nbsp;crude prices recover the ground they lost&nbsp;during the early months of the pandemic.Verizon(VZ)&nbsp;hasn't fared nearly as well — the stock is down nearly 3% this year — but it's still above the lows it hit in March 2020.</p>\n<p>While Buffett has cracked the $100 billion mark, he's still a long way behind the world's richest person,Amazon(AMZN)CEO Jeff Bezos, who is worth $180 billion, according to Bloomberg. Bezos has been trading the title withTesla(TSLA)CEO Elon Musk, who's now worth $173 billion&nbsp;as shares in his electric carmaker rallyfrom recent losses.</p>\n<p>Microsoft(MSFT)co-founder Bill Gates is No. 3 on the list at $138 billion, while Bernard Arnault, the chairman of luxury goods groupLVMH(LVMHF), ranks No. 4 with $122 billion. Arnault is the wealthiest non-American on the list. Zuckerberg is No. 5 with a net worth of $101 billion.Buffett has donated billions of dollars to philanthropic causes, and in 2006, pledged to give away&nbsp;almost all of his fortune to charity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett is now worth $100 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett is now worth $100 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 23:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York/Hong Kong (CNN Business) - Warren Buffett has just joined the world's most exclusive club of the mega rich.\nThe legendary American investor was worth $100 billion on Thursday, according to ...</p>\n\n<a href=\"https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.B":"伯克希尔B","BRK.A":"伯克希尔"},"source_url":"https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119544264","content_text":"New York/Hong Kong (CNN Business) - Warren Buffett has just joined the world's most exclusive club of the mega rich.\nThe legendary American investor was worth $100 billion on Thursday, according to the Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebook(FB)CEO Mark Zuckerberg.\nThe 90-year-old Buffett has added nearly $13 billion to his net worth this year as shares in his industrial and insurance conglomerate have surged.Berkshire Hathaway(BRKA)is up nearly 15% in 2021, giving the company a market capitalization of more than $600 billion.\nBuffett and Berkshire Hathaway are famous for investing primarily in slow growth, \"value\" stocks — many of which have done very well this year as markets continue to recover from the pandemic-fueled crash a year ago. He recently revealed that Berkshire bought stakes in Dow components Chevron and Verizon, indicating a new interest in Big Oil, telecom and media.\nChevron(CVX)is up 31% as crude prices recover the ground they lost during the early months of the pandemic.Verizon(VZ) hasn't fared nearly as well — the stock is down nearly 3% this year — but it's still above the lows it hit in March 2020.\nWhile Buffett has cracked the $100 billion mark, he's still a long way behind the world's richest person,Amazon(AMZN)CEO Jeff Bezos, who is worth $180 billion, according to Bloomberg. Bezos has been trading the title withTesla(TSLA)CEO Elon Musk, who's now worth $173 billion as shares in his electric carmaker rallyfrom recent losses.\nMicrosoft(MSFT)co-founder Bill Gates is No. 3 on the list at $138 billion, while Bernard Arnault, the chairman of luxury goods groupLVMH(LVMHF), ranks No. 4 with $122 billion. Arnault is the wealthiest non-American on the list. Zuckerberg is No. 5 with a net worth of $101 billion.Buffett has donated billions of dollars to philanthropic causes, and in 2006, pledged to give away almost all of his fortune to charity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329180815,"gmtCreate":1615215012137,"gmtModify":1704779690319,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Really? ?","listText":"Really? ?","text":"Really? ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329180815","repostId":"1177459893","repostType":4,"repost":{"id":"1177459893","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615214915,"share":"https://ttm.financial/m/news/1177459893?lang=&edition=fundamental","pubTime":"2021-03-08 22:48","market":"us","language":"en","title":"AMC Entertainment Holdings Inc. once surged 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177459893","media":"老虎资讯综合","summary":"Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.\n\nWed","content":"<p>Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.</p>\n<p><img src=\"https://static.tigerbbs.com/7bcc04a131fa3f13b77abdd91bf212a7\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Wedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.</p>\n<p>Pachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Entertainment Holdings Inc. once surged 9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Entertainment Holdings Inc. once surged 9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-08 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.</p>\n<p><img src=\"https://static.tigerbbs.com/7bcc04a131fa3f13b77abdd91bf212a7\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Wedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.</p>\n<p>Pachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177459893","content_text":"Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.\n\nWedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.\nPachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362634929,"gmtCreate":1614618648661,"gmtModify":1704773224039,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news! ☺️","listText":"Good news! ☺️","text":"Good news! ☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/362634929","repostId":"1118801983","repostType":4,"repost":{"id":"1118801983","pubTimestamp":1614613243,"share":"https://ttm.financial/m/news/1118801983?lang=&edition=fundamental","pubTime":"2021-03-01 23:40","market":"us","language":"en","title":"S&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap","url":"https://stock-news.laohu8.com/highlight/detail?id=1118801983","media":"Bloomberg","summary":"(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern ","content":"<p>(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.</p><p>Companies tied to economic reopenings and faster growth led the gains on Monday amid a broad-based rally. The S&amp;P 500 was on track for its biggest advance in almost four months, while the Russell 2000 of small caps outperformed major benchmarks. Johnson &amp; Johnson jumped after the Centers for Disease Control and Prevention formally recommended its Covid-19 shot. Zoom Video Communications Inc. advanced ahead of its quarterly results. Benchmark Treasuries were little changed. The dollar fell.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/364c24b3bcbc710be3a811425835ebe8\" tg-width=\"1242\" tg-height=\"554\"><span>*Source From Tiger Trade, EST 10:38</span></p><p>After a week of intense volatility in bond markets, investors piled back into risk assets. Stocks rebounded following a two-week selloff that was triggered by concern that progress in battling the coronavirus as well as massive stimulus have left some areas of the economy at risk of possibly overheating.</p><p>“Equity investors are still looking at the rise in rates mostly as ‘a good thing’ and not yet as a threat, notwithstanding some shaking of the tree in high multiple stocks and other parts of the market last week,” wrote Peter Boockvar, chief investment officer at Bleakley Advisory Group. “The benefits of the vaccines versus the challenge of higher rates will be the theme this year.”</p><p>Bitcoin rallied after a volatile weekend session, riding a broad resurgence in risk assets and a bullish report from Citigroup Inc. The bank’s strategists laid out a case for the digital asset to play a bigger role in the global financial system, saying the cryptocurrency could become “the currency of choice for international trade” in the years ahead.</p><p><b>There are some key events to watch this week:</b></p><p>U.S. Federal Reserve Beige Book is due Wednesday.OPEC+ meeting on output Thursday.U.S. factory orders, initial jobless claims and durable goods orders are due Thursday.The February U.S. employment report on Friday will provide an update on the speed and direction of the nation’s labor market recovery.</p><p>These are some of the main moves in markets:</p><p><b>Stocks</b></p><p>The S&amp;P 500 Index surged 2% as of 10:27 a.m. New York time.The Stoxx Europe 600 Index surged 1.8%.The MSCI Asia Pacific Index climbed 1.8%.The MSCI Emerging Market Index climbed 1.8%.</p><p><b>Currencies</b></p><p>The Bloomberg Dollar Spot Index dipped 0.2%.The euro declined 0.3% to $1.2042.The Japanese yen was little changed at 106.54 per dollar.</p><p><b>Bonds</b></p><p>The yield on 10-year Treasuries rose less than one basis point to 1.41%.Germany’s 10-year yield sank eight basis points to -0.34%.Britain’s 10-year yield decreased seven basis points to 0.747%.</p><p><b>Commodities</b></p><p>West Texas Intermediate crude gained 0.5% to $61.80 a barrel.Gold added 0.2% to $1,738.29 an ounce.Silver strengthened 0.7% to $26.86 per ounce.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-01 23:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.Companies tied to economic reopenings and faster growth ...</p>\n\n<a href=\"https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118801983","content_text":"(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.Companies tied to economic reopenings and faster growth led the gains on Monday amid a broad-based rally. The S&P 500 was on track for its biggest advance in almost four months, while the Russell 2000 of small caps outperformed major benchmarks. Johnson & Johnson jumped after the Centers for Disease Control and Prevention formally recommended its Covid-19 shot. Zoom Video Communications Inc. advanced ahead of its quarterly results. Benchmark Treasuries were little changed. The dollar fell.*Source From Tiger Trade, EST 10:38After a week of intense volatility in bond markets, investors piled back into risk assets. Stocks rebounded following a two-week selloff that was triggered by concern that progress in battling the coronavirus as well as massive stimulus have left some areas of the economy at risk of possibly overheating.“Equity investors are still looking at the rise in rates mostly as ‘a good thing’ and not yet as a threat, notwithstanding some shaking of the tree in high multiple stocks and other parts of the market last week,” wrote Peter Boockvar, chief investment officer at Bleakley Advisory Group. “The benefits of the vaccines versus the challenge of higher rates will be the theme this year.”Bitcoin rallied after a volatile weekend session, riding a broad resurgence in risk assets and a bullish report from Citigroup Inc. The bank’s strategists laid out a case for the digital asset to play a bigger role in the global financial system, saying the cryptocurrency could become “the currency of choice for international trade” in the years ahead.There are some key events to watch this week:U.S. Federal Reserve Beige Book is due Wednesday.OPEC+ meeting on output Thursday.U.S. factory orders, initial jobless claims and durable goods orders are due Thursday.The February U.S. employment report on Friday will provide an update on the speed and direction of the nation’s labor market recovery.These are some of the main moves in markets:StocksThe S&P 500 Index surged 2% as of 10:27 a.m. New York time.The Stoxx Europe 600 Index surged 1.8%.The MSCI Asia Pacific Index climbed 1.8%.The MSCI Emerging Market Index climbed 1.8%.CurrenciesThe Bloomberg Dollar Spot Index dipped 0.2%.The euro declined 0.3% to $1.2042.The Japanese yen was little changed at 106.54 per dollar.BondsThe yield on 10-year Treasuries rose less than one basis point to 1.41%.Germany’s 10-year yield sank eight basis points to -0.34%.Britain’s 10-year yield decreased seven basis points to 0.747%.CommoditiesWest Texas Intermediate crude gained 0.5% to $61.80 a barrel.Gold added 0.2% to $1,738.29 an ounce.Silver strengthened 0.7% to $26.86 per ounce.","news_type":1},"isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360769554,"gmtCreate":1613979717278,"gmtModify":1704886384372,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news! ☺️","listText":"Good news! ☺️","text":"Good news! ☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360769554","repostId":"2113875061","repostType":2,"repost":{"id":"2113875061","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613975392,"share":"https://ttm.financial/m/news/2113875061?lang=&edition=fundamental","pubTime":"2021-02-22 14:29","market":"us","language":"en","title":"Vietnam to start COVID-19 vaccinations in March -state media","url":"https://stock-news.laohu8.com/highlight/detail?id=2113875061","media":"Reuters","summary":"HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with fron","content":"<html><body><p>HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.</p><p>   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca</p><p>  vaccine due to arrive on Feb. 28.   </p><p>   \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.</p><p>   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said. </p><p>   The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.</p><p>   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme. </p><p>   Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.  </p><p>   Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.   </p><p>   The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus. </p><p> (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)</p><p>((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vietnam to start COVID-19 vaccinations in March -state media</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVietnam to start COVID-19 vaccinations in March -state media\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-22 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.</p><p>   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca</p><p>  vaccine due to arrive on Feb. 28.   </p><p>   \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.</p><p>   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said. </p><p>   The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.</p><p>   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme. </p><p>   Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.  </p><p>   Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.   </p><p>   The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus. </p><p> (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)</p><p>((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2113875061","content_text":"HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca  vaccine due to arrive on Feb. 28.      \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said.    The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme.    Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.     Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.      The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus.  (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360601370,"gmtCreate":1613894998090,"gmtModify":1704885767350,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news!&nbsp;","listText":"Good news!&nbsp;","text":"Good news!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360601370","repostId":"2113829252","repostType":2,"repost":{"id":"2113829252","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613891789,"share":"https://ttm.financial/m/news/2113829252?lang=&edition=fundamental","pubTime":"2021-02-21 15:16","market":"us","language":"en","title":"S.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says","url":"https://stock-news.laohu8.com/highlight/detail?id=2113829252","media":"Reuters","summary":"By Josh Smith   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 ","content":"<html><body><p>By Josh Smith</p><p>   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.</p><p>   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.</p><p>   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.</p><p>   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.</p><p>   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.</p><p>   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson &amp; Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.</p><p>   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.</p><p>   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.</p><p>   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992.</p><p> (Reporting by Josh Smith; Editing by Lincoln Feast.)</p><p>((JoshSmith1@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-21 15:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Josh Smith</p><p>   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.</p><p>   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.</p><p>   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.</p><p>   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.</p><p>   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.</p><p>   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson &amp; Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.</p><p>   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.</p><p>   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.</p><p>   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992.</p><p> (Reporting by Josh Smith; Editing by Lincoln Feast.)</p><p>((JoshSmith1@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2113829252","content_text":"By Josh Smith   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson & Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992. (Reporting by Josh Smith; Editing by Lincoln Feast.)((JoshSmith1@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":387751023,"gmtCreate":1613789297262,"gmtModify":1704885042375,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news!&nbsp;","listText":"Good news!&nbsp;","text":"Good news!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/387751023","repostId":"2112493847","repostType":2,"repost":{"id":"2112493847","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613786647,"share":"https://ttm.financial/m/news/2112493847?lang=&edition=fundamental","pubTime":"2021-02-20 10:04","market":"us","language":"en","title":"New Zealand begins COVID-19 vaccinations programme, Australia starts Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2112493847","media":"Reuters","summary":"Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on","content":"<html><body><p>Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.  </p><p>   A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.  </p><p>   In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.</p><p>   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.</p><p>   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"</p><p>   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.</p><p>   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.</p><p>   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.   </p><p>   The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.  </p><p>   Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.</p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)</p><p>((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand begins COVID-19 vaccinations programme, Australia starts Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand begins COVID-19 vaccinations programme, Australia starts Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-20 10:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.  </p><p>   A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.  </p><p>   In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.</p><p>   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.</p><p>   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"</p><p>   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.</p><p>   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.</p><p>   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.   </p><p>   The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.  </p><p>   Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.</p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)</p><p>((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112493847","content_text":"Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.     A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.     In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.      The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.     Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384561805,"gmtCreate":1613661376107,"gmtModify":1704883422964,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good read!&nbsp;","listText":"Good read!&nbsp;","text":"Good read!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384561805","repostId":"1102078157","repostType":4,"repost":{"id":"1102078157","pubTimestamp":1613643052,"share":"https://ttm.financial/m/news/1102078157?lang=&edition=fundamental","pubTime":"2021-02-18 18:10","market":"sg","language":"en","title":"Singapore Exchange hopes to list SPACs as early as this year","url":"https://stock-news.laohu8.com/highlight/detail?id=1102078157","media":"Bloomberg","summary":"[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enoug","content":"<p>[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies&nbsp;this year if it gets enough support from the industry.</p><p>An impending marketconsultation on special purpose acquisition companies&nbsp;(SPAC)this quarter could take some time to get feedback, chief executive officer (CEO) Loh Boon Chye said in an interview Wednesday.</p><p>\"If the market is supportive, we hope to be able to do that sometime this year.\"</p><p>SPACs became a buzzword last year, sprouting by the dozen as the rich and famous - from hedge fund billionaire Bill Ackman to former US Speaker of the House Paul Ryan - and private equity firms rushed to set up new ones.</p><p>SPACs are increasingly seen as an appealing alternative route to public markets because the process avoids the risk and uncertainty of an initial public offering, though they've also been criticised for their structure, where managers - the founders - collect fees as an incentive to find a target and complete a deal. Many blank-cheque companies have turned to Asia to seek takeover targets.</p><p>The concept isn't new to the Singapore exchange. It had initiated a consultation on SPAC listings in 2010 - but there wasn't enough appetite among businesses and investors back then.</p><p>\"The world has changed, capital markets have evolved since then,\" said Mr Loh, who took over as CEO in 2015 after a long career in banking. He added that lower-for-longer interest rates, shorter business cycles, volatile markets and stimulus measures are heightening the need for and the ability to seek capital. SPACs could facilitate that while minimising market risk exposure by providing another avenue for investment, he said.</p><p>SPACs could be a way to revive investor interest in Singapore's stock market. The bourse has struggled to attract big-ticket IPOs over the past few years particularly in hot sectors such as technology. While the market volatility of 2020 was a boon, the value of shares traded remained below its five-year average.</p><p>SGX expects stock market listings this year in various sectors including technology, he said, as it awaits the mega IPO of Thai Beverage's brewery unit. The amount raised in first-time share sales in the city-state slumped to US$914 million last year from US$3.4 billion in 2017, according to data compiled by Bloomberg.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Exchange hopes to list SPACs as early as this year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Exchange hopes to list SPACs as early as this year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-18 18:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enough support from the industry.An impending marketconsultation on special purpose acquisition companies...</p>\n\n<a href=\"https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102078157","content_text":"[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enough support from the industry.An impending marketconsultation on special purpose acquisition companies (SPAC)this quarter could take some time to get feedback, chief executive officer (CEO) Loh Boon Chye said in an interview Wednesday.\"If the market is supportive, we hope to be able to do that sometime this year.\"SPACs became a buzzword last year, sprouting by the dozen as the rich and famous - from hedge fund billionaire Bill Ackman to former US Speaker of the House Paul Ryan - and private equity firms rushed to set up new ones.SPACs are increasingly seen as an appealing alternative route to public markets because the process avoids the risk and uncertainty of an initial public offering, though they've also been criticised for their structure, where managers - the founders - collect fees as an incentive to find a target and complete a deal. Many blank-cheque companies have turned to Asia to seek takeover targets.The concept isn't new to the Singapore exchange. It had initiated a consultation on SPAC listings in 2010 - but there wasn't enough appetite among businesses and investors back then.\"The world has changed, capital markets have evolved since then,\" said Mr Loh, who took over as CEO in 2015 after a long career in banking. He added that lower-for-longer interest rates, shorter business cycles, volatile markets and stimulus measures are heightening the need for and the ability to seek capital. SPACs could facilitate that while minimising market risk exposure by providing another avenue for investment, he said.SPACs could be a way to revive investor interest in Singapore's stock market. The bourse has struggled to attract big-ticket IPOs over the past few years particularly in hot sectors such as technology. While the market volatility of 2020 was a boon, the value of shares traded remained below its five-year average.SGX expects stock market listings this year in various sectors including technology, he said, as it awaits the mega IPO of Thai Beverage's brewery unit. The amount raised in first-time share sales in the city-state slumped to US$914 million last year from US$3.4 billion in 2017, according to data compiled by Bloomberg.","news_type":1},"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384014003,"gmtCreate":1613584707502,"gmtModify":1704882466585,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Wow good news.","listText":"Wow good news.","text":"Wow good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384014003","repostId":"1109567373","repostType":4,"repost":{"id":"1109567373","pubTimestamp":1613557874,"share":"https://ttm.financial/m/news/1109567373?lang=&edition=fundamental","pubTime":"2021-02-17 18:31","market":"us","language":"en","title":"PayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109567373","media":"Barrons","summary":"Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of ","content":"<p>Investors can’t get enough of&nbsp;PayPal Holdings,pushing its market value past&nbsp;Mastercard‘s.</p>\n<p>Shares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306. PayPal’s market value is now $359 billion.Mastercard‘s equity, meanwhile, was worth $339 billion at recent prices around $341.</p>\n<p>Mastercard (MA) andVisa(V), the two major card-processing networks, have been hurt by a slowdown in payment volumes related to the pandemic, particularly in highly profitable cross-border transactions. Both stocks are down around 4% this year and are largely flat over the past 52 weeks.</p>\n<p>PayPal, on the other hand, got a lift as the pandemic sent shoppers online and fueled a surge in digital payments. The company is also developing new revenue streams, aiming to become a digital payments “super app,” expanding into everything from Bitcoin to in-store QR-codes, international money transfers, and new peer-to-peer (P2P) services.</p>\n<p>PayPal outlined its five-year strategy in a presentation to investors last week. And some analysts were clearly impressed. Lisa Ellis of MoffettNathanson raised her price target on the stock to $350, reflecting a variety of sources of growth.</p>\n<p>Just about every facet of the business may bepoisedto double over the next five years. PayPal expects to have 750 million active accounts by 2025, up from 377 million now. It sees total payments volume expanding at a 25% annualized rate, reaching $2.8 trillion by 2025.&nbsp; Revenues are expected to hit more than $50 billion, up from an estimated $25.6 billion this year.</p>\n<p>PayPal also expects to boost adjusted operating margins from 25% to 28%, and sees earnings per share rising an average 22% a year. It’s planning to generate $40 billion in free cash flow over the next five years, targeting 30% to 40% for share repurchases.</p>\n<p>As Ellis points out, PayPal has several stepping stones to hit those targets. One is a new service called Buy Now Pay Later, an interest-free installment plan for consumer purchases. The service is gaining traction, with $750 million of transaction volume in the fourth quarter.</p>\n<p>Anothergrowth driveris cryptocurrencies. PayPal users can now buy and store Bitcoin and other cryptocurrencies on its app. The company aims to allow crypto to be used as a funding source with the 28 million merchants on its platform, acting as a middleman between consumers and businesses. Bitcoinhit a record$50,000 on Tuesday, up 75% this year, and it appears to be driving greater usage of PayPal, which could ultimately lead to higher average revenue per customer.</p>\n<p>PayPal also aims to use its Venmo P2P service as a platform for consumer-to-business payments. And PayPal is making inroads with brick-and-mortar merchants through QR technology for contactless payments in stores.</p>\n<p>Does all of this warrant a higher market value and a steep premium to Mastercard stock? The card network is actually expected to lift revenue and profits at a faster pace in fiscal 2021, according to Ellis, growing revenue 21.7% versus 19% for PayPal. She also sees Mastercard’s earnings per share rising 33.3% versus 17.5% for PayPal’s.</p>\n<p>But the five-year outlook is clearly more favorable for PayPal, with revenue rising 21% a year, compared with 15% for Mastercard, and earnings compounding at a 22% rate, versus 17% for Mastercard.</p>\n<p>The question is whether PayPal’s valuation is getting too rich. At 67 times estimated 2021 per-share earnings, PayPal stock is trading nearly three times more expensive than the S&amp;P 500’s P/E ratio of 23 times earnings. Mastercard goes for 42 times 2021 earnings.</p>\n<p>Nonetheless, Wall Street can’t seem to catch up with PayPal’s fast-rising stock. The average target for the stock price is $309, less than 2% above the recent level.</p>\n<p>“You have to appreciate the earnings power in the model,” says Wedbush analyst Moshe Katri, who maintained a $300 target on the stock after the presentation last week. “The more they’re able to expand user engagement and get to point where users keep going back and using its products, the more the user fees can go up.”</p>\n<p>Whether that means the stock can keep climbing will depend on how quickly it can turn into the super-app that Wall Street has come to expect.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 18:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306....</p>\n\n<a href=\"https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","MA":"万事达"},"source_url":"https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109567373","content_text":"Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306. PayPal’s market value is now $359 billion.Mastercard‘s equity, meanwhile, was worth $339 billion at recent prices around $341.\nMastercard (MA) andVisa(V), the two major card-processing networks, have been hurt by a slowdown in payment volumes related to the pandemic, particularly in highly profitable cross-border transactions. Both stocks are down around 4% this year and are largely flat over the past 52 weeks.\nPayPal, on the other hand, got a lift as the pandemic sent shoppers online and fueled a surge in digital payments. The company is also developing new revenue streams, aiming to become a digital payments “super app,” expanding into everything from Bitcoin to in-store QR-codes, international money transfers, and new peer-to-peer (P2P) services.\nPayPal outlined its five-year strategy in a presentation to investors last week. And some analysts were clearly impressed. Lisa Ellis of MoffettNathanson raised her price target on the stock to $350, reflecting a variety of sources of growth.\nJust about every facet of the business may bepoisedto double over the next five years. PayPal expects to have 750 million active accounts by 2025, up from 377 million now. It sees total payments volume expanding at a 25% annualized rate, reaching $2.8 trillion by 2025.  Revenues are expected to hit more than $50 billion, up from an estimated $25.6 billion this year.\nPayPal also expects to boost adjusted operating margins from 25% to 28%, and sees earnings per share rising an average 22% a year. It’s planning to generate $40 billion in free cash flow over the next five years, targeting 30% to 40% for share repurchases.\nAs Ellis points out, PayPal has several stepping stones to hit those targets. One is a new service called Buy Now Pay Later, an interest-free installment plan for consumer purchases. The service is gaining traction, with $750 million of transaction volume in the fourth quarter.\nAnothergrowth driveris cryptocurrencies. PayPal users can now buy and store Bitcoin and other cryptocurrencies on its app. The company aims to allow crypto to be used as a funding source with the 28 million merchants on its platform, acting as a middleman between consumers and businesses. Bitcoinhit a record$50,000 on Tuesday, up 75% this year, and it appears to be driving greater usage of PayPal, which could ultimately lead to higher average revenue per customer.\nPayPal also aims to use its Venmo P2P service as a platform for consumer-to-business payments. And PayPal is making inroads with brick-and-mortar merchants through QR technology for contactless payments in stores.\nDoes all of this warrant a higher market value and a steep premium to Mastercard stock? The card network is actually expected to lift revenue and profits at a faster pace in fiscal 2021, according to Ellis, growing revenue 21.7% versus 19% for PayPal. She also sees Mastercard’s earnings per share rising 33.3% versus 17.5% for PayPal’s.\nBut the five-year outlook is clearly more favorable for PayPal, with revenue rising 21% a year, compared with 15% for Mastercard, and earnings compounding at a 22% rate, versus 17% for Mastercard.\nThe question is whether PayPal’s valuation is getting too rich. At 67 times estimated 2021 per-share earnings, PayPal stock is trading nearly three times more expensive than the S&P 500’s P/E ratio of 23 times earnings. Mastercard goes for 42 times 2021 earnings.\nNonetheless, Wall Street can’t seem to catch up with PayPal’s fast-rising stock. The average target for the stock price is $309, less than 2% above the recent level.\n“You have to appreciate the earnings power in the model,” says Wedbush analyst Moshe Katri, who maintained a $300 target on the stock after the presentation last week. “The more they’re able to expand user engagement and get to point where users keep going back and using its products, the more the user fees can go up.”\nWhether that means the stock can keep climbing will depend on how quickly it can turn into the super-app that Wall Street has come to expect.","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":385849541,"gmtCreate":1613535409083,"gmtModify":1704881734792,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Is this the reason why apple numbers is decreasing?","listText":"Is this the reason why apple numbers is decreasing?","text":"Is this the reason why apple numbers is decreasing?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385849541","repostId":"1106575642","repostType":4,"repost":{"id":"1106575642","pubTimestamp":1613532872,"share":"https://ttm.financial/m/news/1106575642?lang=&edition=fundamental","pubTime":"2021-02-17 11:34","market":"us","language":"en","title":"Apple iCar Speculation Continues. How Tech and Auto Analysts See the Car.","url":"https://stock-news.laohu8.com/highlight/detail?id=1106575642","media":"Barrons","summary":"Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese c","content":"<p>Speculation about an all-electric, self-driving car&nbsp;produced by Apple&nbsp;just won’t die.</p>\n<p>Now Japanese car maker&nbsp;Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder of an Apple-branded vehicle. The iCar has resulted in a lot of Wall Street&nbsp;research reports, but few hard numbers about what an&nbsp;Apple(AAPL) entry might mean for the global car business. What’s more, tech and car analysts have slightly different takes on what the Apple car means.</p>\n<p>News of a potential Apple car surfaced in December. Those reports were taken seriously by both tech and car analysts because Apple has had car ambitions stretching back years—and because Apple is huge. The tech giant has a market capitalization roughly equal to the market cap of all car makers on the globe, combined. That includes the most valuable car company on the planet:Tesla(TSLA).</p>\n<p>Hyundai Motor(005380.Korea),Kia Motors(000270.Korea), as well as&nbsp;U.S. EVstart-up&nbsp;Canoo(GOEV), have all been&nbsp;tied&nbsp;to Apple in reports. Nissan is the latest car company to be linked. Nissan stock fell almost 3% Monday after Reuters reported Nissan’s denial it was working with Apple.</p>\n<p>Apple, and the car companies, haven’t commented on Apple’s car plans. Apple wasn’t immediately available to comment on Nissan reports on Tuesday.</p>\n<p>Outside of&nbsp;temporary impacts&nbsp;on car companies directly linked to Apple, car stocks aren’t really reacting to iCar news. Crying wolf is one reason: Nothing concrete has come from repeated speculation. And of course, an Apple car would be years away—another reason auto investors aren’t too concerned for the moment.</p>\n<p>That doesn’t mean an Apple car won’t matter, or that news of potential partnerships can be discounted. Wedbush analyst&nbsp;Dan Ives&nbsp;expects a formal announcement in 2021. “At this point it’s a matter of when, not if,&nbsp;Apple&nbsp;will enter the EV race over the next few years,” wrote Ives in a Monday research report. He assigns an 85% probability that Apple will make an announcement in three to six months and calls Hyundai and&nbsp;Volkswagen(VOW.Germany) his top two choices for an Apple partnership.</p>\n<p>Hyundai has its own&nbsp;modular EV platform. That’s one reason Ives likes Hyundai as a possibility, although other auto makers, including&nbsp;General Motors(GM), have&nbsp;similar approaches&nbsp;to electric-vehicle development. Volkswagen, for its part, has big EV ambitions. It is also a&nbsp;large shareholder&nbsp;of&nbsp;QuantumScape(QS), which is&nbsp;pioneering&nbsp;solid-state, lithium anode EV batteries. Those batteries promise lower cost, better safety, faster charging, and more range. Both things could make Volkswagen attractive to a partner.</p>\n<p>Ives covers mainly technology stocks. He covers Apple, rating shares outperform and has a $175 price target for shares. He also covers Telsa stock, rating shares Hold with a $950 price target for shares. Bernstein analyst&nbsp;Toni Sacconaghi, covers both as well. He rates Apple stock Hold and has a $132 price target for shares. He is more bearish on Tesla though. He believes an Apple car would make it harder for Tesla to meet its volume growth goal of 50% a year on average for the next few years. “The automotive market has historically been highly fragmented, with strong regional brands and preferences,” wrote Sacconaghi in a recent research report. “It is uncertain to us that amid massive new competition and entry, the market will ultimately become more consolidated and/or have one outsized winner.”</p>\n<p>That’s bad news for Tesla in his mind. He rates Tesla shares Sell and has a $180 price target for the stock, well below where shares are trading.</p>\n<p>Morgan Stanley analyst&nbsp;Adam Jonas&nbsp;covers cars and not Apple. But he is bullish on Tesla stock, rating shares Buy with an $880 price target. An Apple car entry could speed EV penetration, which would benefit all EV makers. In addition, Tesla “can iterate industry-leading battery technology for another four or five years before Apple may be on the scene,” wrote Jonas in a recent research report. “But at some point, today’s EV players must share the sandbox.”</p>\n<p>More EV players, however, aren’t enough to shake his confidence in Tesla stock. In addition to Tesla, Jonas recommends stock in GM and supplier&nbsp;Aptiv(APTV) to get exposure to the&nbsp;EV theme.</p>\n<p>RBC analyst Joe Spak also covers car stocks. He, like Jonas, rates GM and Aptiv stock Buy but rates Tesla stock Hold. The emergence of an Apple car, for Spak, highlights the need for car makers to adapt at faster rates. “Otherwise they could get left behind, whether it’s by Apple or someone else,” wrote Spak in a recent research report.</p>\n<p>Overall, Wall Street appears to believe few things about the iCar: It will be a premium self-driving product, and will be built by an existing auto maker. It is good news for Apple stock, but it might not be that disruptive to the existing industry—initial volumes will be small, and it will boost consumer interest in EVs. What’s more, news of an Apple car will drive incumbents to improve. Time will tell if that turns out to be how the industry develops.</p>\n<p>Apple car news, again, doesn’t appear to be hitting stocks all that much. Tesla stock is down 2.4% on Tuesday. Apple stock is down 1.6%. The&nbsp;S&amp;P 500,for comparison, is down about 0.1% and the&nbsp;Dow Jones Industrial Average&nbsp;is up about 0.2%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple iCar Speculation Continues. How Tech and Auto Analysts See the Car.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple iCar Speculation Continues. How Tech and Auto Analysts See the Car.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 11:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese car maker Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AAPL":"苹果","GM":"通用汽车"},"source_url":"https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106575642","content_text":"Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese car maker Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder of an Apple-branded vehicle. The iCar has resulted in a lot of Wall Street research reports, but few hard numbers about what an Apple(AAPL) entry might mean for the global car business. What’s more, tech and car analysts have slightly different takes on what the Apple car means.\nNews of a potential Apple car surfaced in December. Those reports were taken seriously by both tech and car analysts because Apple has had car ambitions stretching back years—and because Apple is huge. The tech giant has a market capitalization roughly equal to the market cap of all car makers on the globe, combined. That includes the most valuable car company on the planet:Tesla(TSLA).\nHyundai Motor(005380.Korea),Kia Motors(000270.Korea), as well as U.S. EVstart-up Canoo(GOEV), have all been tied to Apple in reports. Nissan is the latest car company to be linked. Nissan stock fell almost 3% Monday after Reuters reported Nissan’s denial it was working with Apple.\nApple, and the car companies, haven’t commented on Apple’s car plans. Apple wasn’t immediately available to comment on Nissan reports on Tuesday.\nOutside of temporary impacts on car companies directly linked to Apple, car stocks aren’t really reacting to iCar news. Crying wolf is one reason: Nothing concrete has come from repeated speculation. And of course, an Apple car would be years away—another reason auto investors aren’t too concerned for the moment.\nThat doesn’t mean an Apple car won’t matter, or that news of potential partnerships can be discounted. Wedbush analyst Dan Ives expects a formal announcement in 2021. “At this point it’s a matter of when, not if, Apple will enter the EV race over the next few years,” wrote Ives in a Monday research report. He assigns an 85% probability that Apple will make an announcement in three to six months and calls Hyundai and Volkswagen(VOW.Germany) his top two choices for an Apple partnership.\nHyundai has its own modular EV platform. That’s one reason Ives likes Hyundai as a possibility, although other auto makers, including General Motors(GM), have similar approaches to electric-vehicle development. Volkswagen, for its part, has big EV ambitions. It is also a large shareholder of QuantumScape(QS), which is pioneering solid-state, lithium anode EV batteries. Those batteries promise lower cost, better safety, faster charging, and more range. Both things could make Volkswagen attractive to a partner.\nIves covers mainly technology stocks. He covers Apple, rating shares outperform and has a $175 price target for shares. He also covers Telsa stock, rating shares Hold with a $950 price target for shares. Bernstein analyst Toni Sacconaghi, covers both as well. He rates Apple stock Hold and has a $132 price target for shares. He is more bearish on Tesla though. He believes an Apple car would make it harder for Tesla to meet its volume growth goal of 50% a year on average for the next few years. “The automotive market has historically been highly fragmented, with strong regional brands and preferences,” wrote Sacconaghi in a recent research report. “It is uncertain to us that amid massive new competition and entry, the market will ultimately become more consolidated and/or have one outsized winner.”\nThat’s bad news for Tesla in his mind. He rates Tesla shares Sell and has a $180 price target for the stock, well below where shares are trading.\nMorgan Stanley analyst Adam Jonas covers cars and not Apple. But he is bullish on Tesla stock, rating shares Buy with an $880 price target. An Apple car entry could speed EV penetration, which would benefit all EV makers. In addition, Tesla “can iterate industry-leading battery technology for another four or five years before Apple may be on the scene,” wrote Jonas in a recent research report. “But at some point, today’s EV players must share the sandbox.”\nMore EV players, however, aren’t enough to shake his confidence in Tesla stock. In addition to Tesla, Jonas recommends stock in GM and supplier Aptiv(APTV) to get exposure to the EV theme.\nRBC analyst Joe Spak also covers car stocks. He, like Jonas, rates GM and Aptiv stock Buy but rates Tesla stock Hold. The emergence of an Apple car, for Spak, highlights the need for car makers to adapt at faster rates. “Otherwise they could get left behind, whether it’s by Apple or someone else,” wrote Spak in a recent research report.\nOverall, Wall Street appears to believe few things about the iCar: It will be a premium self-driving product, and will be built by an existing auto maker. It is good news for Apple stock, but it might not be that disruptive to the existing industry—initial volumes will be small, and it will boost consumer interest in EVs. What’s more, news of an Apple car will drive incumbents to improve. Time will tell if that turns out to be how the industry develops.\nApple car news, again, doesn’t appear to be hitting stocks all that much. Tesla stock is down 2.4% on Tuesday. Apple stock is down 1.6%. The S&P 500,for comparison, is down about 0.1% and the Dow Jones Industrial Average is up about 0.2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382414416,"gmtCreate":1613474879735,"gmtModify":1704880875930,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382414416","repostId":"1108705396","repostType":4,"repost":{"id":"1108705396","pubTimestamp":1613469786,"share":"https://ttm.financial/m/news/1108705396?lang=&edition=fundamental","pubTime":"2021-02-16 18:03","market":"us","language":"en","title":"With Biden going big, Wall Street economists are growing bullish on the US economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705396","media":"CNN Business","summary":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl","content":"<p><b>New York (CNN Business)&nbsp;</b>The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington&nbsp;and millions of families were about to&nbsp;lose crucial benefits.</p>\n<p>Fast forward two months, and the&nbsp;economy is still struggling-- but confidence in the recovery is growing, rapidly.</p>\n<p>Economists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.</p>\n<p>The renewed optimism is being driven by two major factors: the&nbsp;health crisis is easing&nbsp;and Uncle Sam is&nbsp;coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.</p>\n<p>After supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.</p>\n<p>\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.</p>\n<p>The turning point happened last month&nbsp;when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for&nbsp;President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.</p>\n<p><b>'Summer mini-boom'</b></p>\n<p>Before the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a&nbsp;forecast by Treasury Secretary Janet Yellen.</p>\n<p>\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.</p>\n<p>Oxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.</p>\n<p>Likewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"</p>\n<p>\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.</p>\n<p>Indeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.</p>\n<p>The rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.</p>\n<p><b>Double-dip recession averted</b></p>\n<p>The Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.</p>\n<p>For months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.</p>\n<p>At the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.</p>\n<p>\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.</p>\n<p>Slammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States&nbsp;added just 49,000 jobs in January.</p>\n<p>Jobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.</p>\n<p><b>Vaccines to the rescue</b></p>\n<p>But there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.</p>\n<p>Critically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.</p>\n<p>And Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday&nbsp;that the United States may be able to vaccinate most Americans by the middle or end of summer.</p>\n<p>All of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.</p>\n<p>That's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants&nbsp;force US states and cities to once again tighten health restrictions.</p>\n<p><b>Low-wage workers are still hurting badly</b></p>\n<p>Against this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.</p>\n<p>\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"</p>\n<p>Doing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.</p>\n<p>Employment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.</p>\n<p>\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.</p>\n<p>However, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.</p>\n<p>\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.</p>\n<p><b>'Bring it on'</b></p>\n<p>Some economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington&nbsp;overheats the economy by injecting too much support.</p>\n<p>\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.</p>\n<p>And that in turn would spook the&nbsp;red-hot stock market.</p>\n<p>Fed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.</p>\n<p>Citing \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.</p>\n<p>Zandi isn't losing sleep over inflation, mostly because the United States is far from full employment.</p>\n<p>\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Biden going big, Wall Street economists are growing bullish on the US economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Biden going big, Wall Street economists are growing bullish on the US economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 18:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108705396","content_text":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and millions of families were about to lose crucial benefits.\nFast forward two months, and the economy is still struggling-- but confidence in the recovery is growing, rapidly.\nEconomists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.\nThe renewed optimism is being driven by two major factors: the health crisis is easing and Uncle Sam is coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.\nAfter supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.\n\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.\nThe turning point happened last month when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.\n'Summer mini-boom'\nBefore the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a forecast by Treasury Secretary Janet Yellen.\n\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.\nOxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.\nLikewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"\n\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.\nIndeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.\nThe rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.\nDouble-dip recession averted\nThe Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.\nFor months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.\nAt the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.\n\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.\nSlammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States added just 49,000 jobs in January.\nJobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.\nVaccines to the rescue\nBut there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.\nCritically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.\nAnd Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday that the United States may be able to vaccinate most Americans by the middle or end of summer.\nAll of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.\nThat's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants force US states and cities to once again tighten health restrictions.\nLow-wage workers are still hurting badly\nAgainst this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.\n\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"\nDoing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.\nEmployment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.\n\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.\nHowever, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.\n\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.\n'Bring it on'\nSome economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington overheats the economy by injecting too much support.\n\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.\nAnd that in turn would spook the red-hot stock market.\nFed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.\nCiting \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.\nZandi isn't losing sleep over inflation, mostly because the United States is far from full employment.\n\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":29,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382414966,"gmtCreate":1613474829855,"gmtModify":1704880874940,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Nice to know","listText":"Nice to know","text":"Nice to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382414966","repostId":"1108705396","repostType":4,"repost":{"id":"1108705396","pubTimestamp":1613469786,"share":"https://ttm.financial/m/news/1108705396?lang=&edition=fundamental","pubTime":"2021-02-16 18:03","market":"us","language":"en","title":"With Biden going big, Wall Street economists are growing bullish on the US economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705396","media":"CNN Business","summary":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl","content":"<p><b>New York (CNN Business)&nbsp;</b>The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington&nbsp;and millions of families were about to&nbsp;lose crucial benefits.</p>\n<p>Fast forward two months, and the&nbsp;economy is still struggling-- but confidence in the recovery is growing, rapidly.</p>\n<p>Economists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.</p>\n<p>The renewed optimism is being driven by two major factors: the&nbsp;health crisis is easing&nbsp;and Uncle Sam is&nbsp;coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.</p>\n<p>After supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.</p>\n<p>\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.</p>\n<p>The turning point happened last month&nbsp;when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for&nbsp;President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.</p>\n<p><b>'Summer mini-boom'</b></p>\n<p>Before the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a&nbsp;forecast by Treasury Secretary Janet Yellen.</p>\n<p>\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.</p>\n<p>Oxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.</p>\n<p>Likewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"</p>\n<p>\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.</p>\n<p>Indeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.</p>\n<p>The rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.</p>\n<p><b>Double-dip recession averted</b></p>\n<p>The Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.</p>\n<p>For months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.</p>\n<p>At the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.</p>\n<p>\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.</p>\n<p>Slammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States&nbsp;added just 49,000 jobs in January.</p>\n<p>Jobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.</p>\n<p><b>Vaccines to the rescue</b></p>\n<p>But there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.</p>\n<p>Critically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.</p>\n<p>And Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday&nbsp;that the United States may be able to vaccinate most Americans by the middle or end of summer.</p>\n<p>All of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.</p>\n<p>That's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants&nbsp;force US states and cities to once again tighten health restrictions.</p>\n<p><b>Low-wage workers are still hurting badly</b></p>\n<p>Against this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.</p>\n<p>\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"</p>\n<p>Doing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.</p>\n<p>Employment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.</p>\n<p>\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.</p>\n<p>However, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.</p>\n<p>\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.</p>\n<p><b>'Bring it on'</b></p>\n<p>Some economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington&nbsp;overheats the economy by injecting too much support.</p>\n<p>\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.</p>\n<p>And that in turn would spook the&nbsp;red-hot stock market.</p>\n<p>Fed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.</p>\n<p>Citing \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.</p>\n<p>Zandi isn't losing sleep over inflation, mostly because the United States is far from full employment.</p>\n<p>\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Biden going big, Wall Street economists are growing bullish on the US economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Biden going big, Wall Street economists are growing bullish on the US economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 18:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108705396","content_text":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and millions of families were about to lose crucial benefits.\nFast forward two months, and the economy is still struggling-- but confidence in the recovery is growing, rapidly.\nEconomists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.\nThe renewed optimism is being driven by two major factors: the health crisis is easing and Uncle Sam is coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.\nAfter supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.\n\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.\nThe turning point happened last month when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.\n'Summer mini-boom'\nBefore the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a forecast by Treasury Secretary Janet Yellen.\n\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.\nOxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.\nLikewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"\n\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.\nIndeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.\nThe rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.\nDouble-dip recession averted\nThe Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.\nFor months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.\nAt the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.\n\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.\nSlammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States added just 49,000 jobs in January.\nJobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.\nVaccines to the rescue\nBut there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.\nCritically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.\nAnd Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday that the United States may be able to vaccinate most Americans by the middle or end of summer.\nAll of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.\nThat's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants force US states and cities to once again tighten health restrictions.\nLow-wage workers are still hurting badly\nAgainst this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.\n\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"\nDoing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.\nEmployment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.\n\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.\nHowever, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.\n\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.\n'Bring it on'\nSome economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington overheats the economy by injecting too much support.\n\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.\nAnd that in turn would spook the red-hot stock market.\nFed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.\nCiting \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.\nZandi isn't losing sleep over inflation, mostly because the United States is far from full employment.\n\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382914803,"gmtCreate":1613348289502,"gmtModify":1704879952212,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good to know and hope everyone in the world will&nbsp;be vaccinated.","listText":"Good to know and hope everyone in the world will&nbsp;be vaccinated.","text":"Good to know and hope everyone in the world will be vaccinated.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382914803","repostId":"2111082770","repostType":2,"repost":{"id":"2111082770","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613331277,"share":"https://ttm.financial/m/news/2111082770?lang=&edition=fundamental","pubTime":"2021-02-15 03:34","market":"us","language":"en","title":"Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2111082770","media":"Reuters","summary":"JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in ","content":"<html><body><p>JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.</p><p>   Health maintenance organization <a href=\"https://laohu8.com/S/HMO.AU\">$(HMO.AU)$</a> Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus. </p><p>   The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine. </p><p>   \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.</p><p>   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.</p><p>   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.</p><p>   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.</p><p>   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.  </p><p> (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)</p><p>((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-15 03:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.</p><p>   Health maintenance organization <a href=\"https://laohu8.com/S/HMO.AU\">$(HMO.AU)$</a> Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus. </p><p>   The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine. </p><p>   \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.</p><p>   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.</p><p>   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.</p><p>   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.</p><p>   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.  </p><p> (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)</p><p>((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111082770","content_text":"JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.   Health maintenance organization $(HMO.AU)$ Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.    The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.    \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.   (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386453205,"gmtCreate":1613262838907,"gmtModify":1704879598206,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Better wait for safe vaccine than sorry. ?","listText":"Better wait for safe vaccine than sorry. ?","text":"Better wait for safe vaccine than sorry. ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/386453205","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://ttm.financial/m/news/2111807728?lang=&edition=fundamental","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-14 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","TBIO":"TELESIS BIO"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":362634929,"gmtCreate":1614618648661,"gmtModify":1704773224039,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news! ☺️","listText":"Good news! ☺️","text":"Good news! ☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/362634929","repostId":"1118801983","repostType":4,"repost":{"id":"1118801983","pubTimestamp":1614613243,"share":"https://ttm.financial/m/news/1118801983?lang=&edition=fundamental","pubTime":"2021-03-01 23:40","market":"us","language":"en","title":"S&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap","url":"https://stock-news.laohu8.com/highlight/detail?id=1118801983","media":"Bloomberg","summary":"(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern ","content":"<p>(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.</p><p>Companies tied to economic reopenings and faster growth led the gains on Monday amid a broad-based rally. The S&amp;P 500 was on track for its biggest advance in almost four months, while the Russell 2000 of small caps outperformed major benchmarks. Johnson &amp; Johnson jumped after the Centers for Disease Control and Prevention formally recommended its Covid-19 shot. Zoom Video Communications Inc. advanced ahead of its quarterly results. Benchmark Treasuries were little changed. The dollar fell.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/364c24b3bcbc710be3a811425835ebe8\" tg-width=\"1242\" tg-height=\"554\"><span>*Source From Tiger Trade, EST 10:38</span></p><p>After a week of intense volatility in bond markets, investors piled back into risk assets. Stocks rebounded following a two-week selloff that was triggered by concern that progress in battling the coronavirus as well as massive stimulus have left some areas of the economy at risk of possibly overheating.</p><p>“Equity investors are still looking at the rise in rates mostly as ‘a good thing’ and not yet as a threat, notwithstanding some shaking of the tree in high multiple stocks and other parts of the market last week,” wrote Peter Boockvar, chief investment officer at Bleakley Advisory Group. “The benefits of the vaccines versus the challenge of higher rates will be the theme this year.”</p><p>Bitcoin rallied after a volatile weekend session, riding a broad resurgence in risk assets and a bullish report from Citigroup Inc. The bank’s strategists laid out a case for the digital asset to play a bigger role in the global financial system, saying the cryptocurrency could become “the currency of choice for international trade” in the years ahead.</p><p><b>There are some key events to watch this week:</b></p><p>U.S. Federal Reserve Beige Book is due Wednesday.OPEC+ meeting on output Thursday.U.S. factory orders, initial jobless claims and durable goods orders are due Thursday.The February U.S. employment report on Friday will provide an update on the speed and direction of the nation’s labor market recovery.</p><p>These are some of the main moves in markets:</p><p><b>Stocks</b></p><p>The S&amp;P 500 Index surged 2% as of 10:27 a.m. New York time.The Stoxx Europe 600 Index surged 1.8%.The MSCI Asia Pacific Index climbed 1.8%.The MSCI Emerging Market Index climbed 1.8%.</p><p><b>Currencies</b></p><p>The Bloomberg Dollar Spot Index dipped 0.2%.The euro declined 0.3% to $1.2042.The Japanese yen was little changed at 106.54 per dollar.</p><p><b>Bonds</b></p><p>The yield on 10-year Treasuries rose less than one basis point to 1.41%.Germany’s 10-year yield sank eight basis points to -0.34%.Britain’s 10-year yield decreased seven basis points to 0.747%.</p><p><b>Commodities</b></p><p>West Texas Intermediate crude gained 0.5% to $61.80 a barrel.Gold added 0.2% to $1,738.29 an ounce.Silver strengthened 0.7% to $26.86 per ounce.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Climbs 2% Amid Rally Led by Small Caps: Markets Wrap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-01 23:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.Companies tied to economic reopenings and faster growth ...</p>\n\n<a href=\"https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/yields-focus-stocks-set-open-202935160.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118801983","content_text":"(Bloomberg) -- Stocks climbed as confidence returned to markets, with investors shaking off concern about the impacts of higher Treasury yields.Companies tied to economic reopenings and faster growth led the gains on Monday amid a broad-based rally. The S&P 500 was on track for its biggest advance in almost four months, while the Russell 2000 of small caps outperformed major benchmarks. Johnson & Johnson jumped after the Centers for Disease Control and Prevention formally recommended its Covid-19 shot. Zoom Video Communications Inc. advanced ahead of its quarterly results. Benchmark Treasuries were little changed. The dollar fell.*Source From Tiger Trade, EST 10:38After a week of intense volatility in bond markets, investors piled back into risk assets. Stocks rebounded following a two-week selloff that was triggered by concern that progress in battling the coronavirus as well as massive stimulus have left some areas of the economy at risk of possibly overheating.“Equity investors are still looking at the rise in rates mostly as ‘a good thing’ and not yet as a threat, notwithstanding some shaking of the tree in high multiple stocks and other parts of the market last week,” wrote Peter Boockvar, chief investment officer at Bleakley Advisory Group. “The benefits of the vaccines versus the challenge of higher rates will be the theme this year.”Bitcoin rallied after a volatile weekend session, riding a broad resurgence in risk assets and a bullish report from Citigroup Inc. The bank’s strategists laid out a case for the digital asset to play a bigger role in the global financial system, saying the cryptocurrency could become “the currency of choice for international trade” in the years ahead.There are some key events to watch this week:U.S. Federal Reserve Beige Book is due Wednesday.OPEC+ meeting on output Thursday.U.S. factory orders, initial jobless claims and durable goods orders are due Thursday.The February U.S. employment report on Friday will provide an update on the speed and direction of the nation’s labor market recovery.These are some of the main moves in markets:StocksThe S&P 500 Index surged 2% as of 10:27 a.m. New York time.The Stoxx Europe 600 Index surged 1.8%.The MSCI Asia Pacific Index climbed 1.8%.The MSCI Emerging Market Index climbed 1.8%.CurrenciesThe Bloomberg Dollar Spot Index dipped 0.2%.The euro declined 0.3% to $1.2042.The Japanese yen was little changed at 106.54 per dollar.BondsThe yield on 10-year Treasuries rose less than one basis point to 1.41%.Germany’s 10-year yield sank eight basis points to -0.34%.Britain’s 10-year yield decreased seven basis points to 0.747%.CommoditiesWest Texas Intermediate crude gained 0.5% to $61.80 a barrel.Gold added 0.2% to $1,738.29 an ounce.Silver strengthened 0.7% to $26.86 per ounce.","news_type":1},"isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329180815,"gmtCreate":1615215012137,"gmtModify":1704779690319,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Really? ?","listText":"Really? ?","text":"Really? ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/329180815","repostId":"1177459893","repostType":4,"repost":{"id":"1177459893","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615214915,"share":"https://ttm.financial/m/news/1177459893?lang=&edition=fundamental","pubTime":"2021-03-08 22:48","market":"us","language":"en","title":"AMC Entertainment Holdings Inc. once surged 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177459893","media":"老虎资讯综合","summary":"Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.\n\nWed","content":"<p>Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.</p>\n<p><img src=\"https://static.tigerbbs.com/7bcc04a131fa3f13b77abdd91bf212a7\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Wedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.</p>\n<p>Pachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Entertainment Holdings Inc. once surged 9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Entertainment Holdings Inc. once surged 9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-08 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.</p>\n<p><img src=\"https://static.tigerbbs.com/7bcc04a131fa3f13b77abdd91bf212a7\" tg-width=\"840\" tg-height=\"470\"></p>\n<p>Wedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.</p>\n<p>Pachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177459893","content_text":"Shares of AMC Entertainment Holdings Inc. once surged 9% after price target doubled at Wedbush.\n\nWedbush analyst Michael Pachter doubled his price target ahead of the company’s earnings report, citing an increasing optimism over the post-pandemic environment.\nPachter raised his target for the stock to $5.00 from $2.50, but that target was 38% below Friday’s closing price of $8.05. He reiterated the neutral rating he’s had on AMC since March 2020, however, saying it was “tough to get positive here, despite rising industry optimism.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386453205,"gmtCreate":1613262838907,"gmtModify":1704879598206,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Better wait for safe vaccine than sorry. ?","listText":"Better wait for safe vaccine than sorry. ?","text":"Better wait for safe vaccine than sorry. ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/386453205","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://ttm.financial/m/news/2111807728?lang=&edition=fundamental","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-14 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","TBIO":"TELESIS BIO"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382414416,"gmtCreate":1613474879735,"gmtModify":1704880875930,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382414416","repostId":"1108705396","repostType":4,"repost":{"id":"1108705396","pubTimestamp":1613469786,"share":"https://ttm.financial/m/news/1108705396?lang=&edition=fundamental","pubTime":"2021-02-16 18:03","market":"us","language":"en","title":"With Biden going big, Wall Street economists are growing bullish on the US economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705396","media":"CNN Business","summary":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl","content":"<p><b>New York (CNN Business)&nbsp;</b>The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington&nbsp;and millions of families were about to&nbsp;lose crucial benefits.</p>\n<p>Fast forward two months, and the&nbsp;economy is still struggling-- but confidence in the recovery is growing, rapidly.</p>\n<p>Economists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.</p>\n<p>The renewed optimism is being driven by two major factors: the&nbsp;health crisis is easing&nbsp;and Uncle Sam is&nbsp;coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.</p>\n<p>After supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.</p>\n<p>\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.</p>\n<p>The turning point happened last month&nbsp;when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for&nbsp;President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.</p>\n<p><b>'Summer mini-boom'</b></p>\n<p>Before the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a&nbsp;forecast by Treasury Secretary Janet Yellen.</p>\n<p>\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.</p>\n<p>Oxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.</p>\n<p>Likewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"</p>\n<p>\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.</p>\n<p>Indeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.</p>\n<p>The rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.</p>\n<p><b>Double-dip recession averted</b></p>\n<p>The Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.</p>\n<p>For months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.</p>\n<p>At the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.</p>\n<p>\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.</p>\n<p>Slammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States&nbsp;added just 49,000 jobs in January.</p>\n<p>Jobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.</p>\n<p><b>Vaccines to the rescue</b></p>\n<p>But there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.</p>\n<p>Critically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.</p>\n<p>And Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday&nbsp;that the United States may be able to vaccinate most Americans by the middle or end of summer.</p>\n<p>All of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.</p>\n<p>That's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants&nbsp;force US states and cities to once again tighten health restrictions.</p>\n<p><b>Low-wage workers are still hurting badly</b></p>\n<p>Against this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.</p>\n<p>\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"</p>\n<p>Doing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.</p>\n<p>Employment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.</p>\n<p>\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.</p>\n<p>However, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.</p>\n<p>\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.</p>\n<p><b>'Bring it on'</b></p>\n<p>Some economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington&nbsp;overheats the economy by injecting too much support.</p>\n<p>\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.</p>\n<p>And that in turn would spook the&nbsp;red-hot stock market.</p>\n<p>Fed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.</p>\n<p>Citing \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.</p>\n<p>Zandi isn't losing sleep over inflation, mostly because the United States is far from full employment.</p>\n<p>\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Biden going big, Wall Street economists are growing bullish on the US economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Biden going big, Wall Street economists are growing bullish on the US economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 18:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108705396","content_text":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and millions of families were about to lose crucial benefits.\nFast forward two months, and the economy is still struggling-- but confidence in the recovery is growing, rapidly.\nEconomists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.\nThe renewed optimism is being driven by two major factors: the health crisis is easing and Uncle Sam is coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.\nAfter supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.\n\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.\nThe turning point happened last month when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.\n'Summer mini-boom'\nBefore the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a forecast by Treasury Secretary Janet Yellen.\n\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.\nOxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.\nLikewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"\n\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.\nIndeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.\nThe rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.\nDouble-dip recession averted\nThe Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.\nFor months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.\nAt the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.\n\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.\nSlammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States added just 49,000 jobs in January.\nJobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.\nVaccines to the rescue\nBut there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.\nCritically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.\nAnd Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday that the United States may be able to vaccinate most Americans by the middle or end of summer.\nAll of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.\nThat's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants force US states and cities to once again tighten health restrictions.\nLow-wage workers are still hurting badly\nAgainst this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.\n\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"\nDoing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.\nEmployment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.\n\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.\nHowever, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.\n\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.\n'Bring it on'\nSome economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington overheats the economy by injecting too much support.\n\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.\nAnd that in turn would spook the red-hot stock market.\nFed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.\nCiting \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.\nZandi isn't losing sleep over inflation, mostly because the United States is far from full employment.\n\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":29,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328150862,"gmtCreate":1615508192156,"gmtModify":1704783777345,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"[666]&nbsp;","listText":"[666]&nbsp;","text":"[666]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328150862","repostId":"1119544264","repostType":4,"repost":{"id":"1119544264","pubTimestamp":1615476407,"share":"https://ttm.financial/m/news/1119544264?lang=&edition=fundamental","pubTime":"2021-03-11 23:26","market":"us","language":"en","title":"Warren Buffett is now worth $100 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1119544264","media":"CNN Business","summary":"New York/Hong Kong  - Warren Buffett has just joined the world's most exclusive club of the mega rich.The legendary American investor was worth $100 billion on Thursday, according to the Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebookCEO Mark Zuckerberg.The 90-year-old Buffett has added nearly $13 billion to his net worth this year as shares in his industrial a","content":"<p><b>New York/Hong Kong (CNN Business)&nbsp;-&nbsp;</b>Warren Buffett has just joined the world's most exclusive club of the mega rich.</p>\n<p>The legendary American investor was worth $100 billion on Thursday, according to the&nbsp;Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebook(FB)CEO Mark&nbsp;Zuckerberg.</p>\n<p>The 90-year-old&nbsp;Buffett&nbsp;has added nearly $13 billion to his net worth this year as shares in his industrial and insurance conglomerate have surged.Berkshire Hathaway(BRKA)is up nearly 15% in 2021, giving the company a market capitalization of more than $600 billion.</p>\n<p>Buffett and Berkshire Hathaway are famous for investing primarily in slow growth, \"value\" stocks — many of which have done very well this year as markets continue to recover from the pandemic-fueled crash a year ago. He recently revealed that Berkshire&nbsp;bought stakes in Dow components&nbsp;Chevron and Verizon, indicating a new interest in Big Oil, telecom and media.</p>\n<p>Chevron(CVX)is up 31% as&nbsp;crude prices recover the ground they lost&nbsp;during the early months of the pandemic.Verizon(VZ)&nbsp;hasn't fared nearly as well — the stock is down nearly 3% this year — but it's still above the lows it hit in March 2020.</p>\n<p>While Buffett has cracked the $100 billion mark, he's still a long way behind the world's richest person,Amazon(AMZN)CEO Jeff Bezos, who is worth $180 billion, according to Bloomberg. Bezos has been trading the title withTesla(TSLA)CEO Elon Musk, who's now worth $173 billion&nbsp;as shares in his electric carmaker rallyfrom recent losses.</p>\n<p>Microsoft(MSFT)co-founder Bill Gates is No. 3 on the list at $138 billion, while Bernard Arnault, the chairman of luxury goods groupLVMH(LVMHF), ranks No. 4 with $122 billion. Arnault is the wealthiest non-American on the list. Zuckerberg is No. 5 with a net worth of $101 billion.Buffett has donated billions of dollars to philanthropic causes, and in 2006, pledged to give away&nbsp;almost all of his fortune to charity.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett is now worth $100 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett is now worth $100 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-11 23:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York/Hong Kong (CNN Business) - Warren Buffett has just joined the world's most exclusive club of the mega rich.\nThe legendary American investor was worth $100 billion on Thursday, according to ...</p>\n\n<a href=\"https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.B":"伯克希尔B","BRK.A":"伯克希尔"},"source_url":"https://edition.cnn.com/2021/03/11/business/warren-buffett-net-worth-intl-hnk/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119544264","content_text":"New York/Hong Kong (CNN Business) - Warren Buffett has just joined the world's most exclusive club of the mega rich.\nThe legendary American investor was worth $100 billion on Thursday, according to the Bloomberg Billionaire's Index. That puts him in the company of just five other men above that threshold. And he's now the sixth richest person in the world, ranking just behindFacebook(FB)CEO Mark Zuckerberg.\nThe 90-year-old Buffett has added nearly $13 billion to his net worth this year as shares in his industrial and insurance conglomerate have surged.Berkshire Hathaway(BRKA)is up nearly 15% in 2021, giving the company a market capitalization of more than $600 billion.\nBuffett and Berkshire Hathaway are famous for investing primarily in slow growth, \"value\" stocks — many of which have done very well this year as markets continue to recover from the pandemic-fueled crash a year ago. He recently revealed that Berkshire bought stakes in Dow components Chevron and Verizon, indicating a new interest in Big Oil, telecom and media.\nChevron(CVX)is up 31% as crude prices recover the ground they lost during the early months of the pandemic.Verizon(VZ) hasn't fared nearly as well — the stock is down nearly 3% this year — but it's still above the lows it hit in March 2020.\nWhile Buffett has cracked the $100 billion mark, he's still a long way behind the world's richest person,Amazon(AMZN)CEO Jeff Bezos, who is worth $180 billion, according to Bloomberg. Bezos has been trading the title withTesla(TSLA)CEO Elon Musk, who's now worth $173 billion as shares in his electric carmaker rallyfrom recent losses.\nMicrosoft(MSFT)co-founder Bill Gates is No. 3 on the list at $138 billion, while Bernard Arnault, the chairman of luxury goods groupLVMH(LVMHF), ranks No. 4 with $122 billion. Arnault is the wealthiest non-American on the list. Zuckerberg is No. 5 with a net worth of $101 billion.Buffett has donated billions of dollars to philanthropic causes, and in 2006, pledged to give away almost all of his fortune to charity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360601370,"gmtCreate":1613894998090,"gmtModify":1704885767350,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news!&nbsp;","listText":"Good news!&nbsp;","text":"Good news!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360601370","repostId":"2113829252","repostType":2,"repost":{"id":"2113829252","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613891789,"share":"https://ttm.financial/m/news/2113829252?lang=&edition=fundamental","pubTime":"2021-02-21 15:16","market":"us","language":"en","title":"S.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says","url":"https://stock-news.laohu8.com/highlight/detail?id=2113829252","media":"Reuters","summary":"By Josh Smith   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 ","content":"<html><body><p>By Josh Smith</p><p>   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.</p><p>   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.</p><p>   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.</p><p>   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.</p><p>   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.</p><p>   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson &amp; Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.</p><p>   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.</p><p>   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.</p><p>   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992.</p><p> (Reporting by Josh Smith; Editing by Lincoln Feast.)</p><p>((JoshSmith1@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS.Korea to begin using Pfizer coronavirus vaccines on Feb. 27, PM says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-21 15:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Josh Smith</p><p>   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.</p><p>   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.</p><p>   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.</p><p>   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.</p><p>   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.</p><p>   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson &amp; Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.</p><p>   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.</p><p>   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.</p><p>   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992.</p><p> (Reporting by Josh Smith; Editing by Lincoln Feast.)</p><p>((JoshSmith1@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2113829252","content_text":"By Josh Smith   SEOUL, Feb 21 (Reuters) - South Korea will begin administering the first of 117,000 doses of Pfizer's    coronavirus vaccine on Feb. 27, a day after the country begins its first vaccinations with AstraZeneca's products, the prime minister announced on Sunday.   Plans call for about 10 million high-risk people, including health care workers and staffers and some residents of assisted care facilities and nursing homes, to be inoculated by July.   The first AstraZeneca    vaccines are scheduled to be administered on Friday, with Pfizer's shots being deployed the next day, Prime Minister Chung Sye-kyun said in remarks reported by Yonhap news agency.   \"On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the vaccines will be administered to medical staff treating coronavirus patients starting on Feb. 27,\" Chung told a government meeting, according to Yonhap.   The authorities have said they will not use AstraZeneca vaccine on people aged 65 and older until more efficacy data becomes available, reversing an earlier decision.   Aside from AstraZeneca and Pfizer, South Korea has also reached agreements with Moderna, Novavax Inc, Johnson & Johnson, and global vaccine-sharing scheme COVAX, for the supply of their vaccines.   Chung announced last week that South Korea had struck additional deals with Novavax Inc for enough vaccines to cover 20 million people and with Pfizer to cover a further 3 million, making the total supply enough to cover 79 million people, though South Korea has a population of 52 million.   The government says its goal is to reach herd immunity by November, though leading South Korean medical experts have said that timetable will be practically impossible to achieve.   The Korea Disease Control and Prevention Agency reported 416 more COVID-19 cases as of midnight Saturday, raising the total to 86,992. (Reporting by Josh Smith; Editing by Lincoln Feast.)((JoshSmith1@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382414966,"gmtCreate":1613474829855,"gmtModify":1704880874940,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Nice to know","listText":"Nice to know","text":"Nice to know","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382414966","repostId":"1108705396","repostType":4,"repost":{"id":"1108705396","pubTimestamp":1613469786,"share":"https://ttm.financial/m/news/1108705396?lang=&edition=fundamental","pubTime":"2021-02-16 18:03","market":"us","language":"en","title":"With Biden going big, Wall Street economists are growing bullish on the US economy","url":"https://stock-news.laohu8.com/highlight/detail?id=1108705396","media":"CNN Business","summary":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a doubl","content":"<p><b>New York (CNN Business)&nbsp;</b>The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington&nbsp;and millions of families were about to&nbsp;lose crucial benefits.</p>\n<p>Fast forward two months, and the&nbsp;economy is still struggling-- but confidence in the recovery is growing, rapidly.</p>\n<p>Economists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.</p>\n<p>The renewed optimism is being driven by two major factors: the&nbsp;health crisis is easing&nbsp;and Uncle Sam is&nbsp;coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.</p>\n<p>After supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.</p>\n<p>\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.</p>\n<p>The turning point happened last month&nbsp;when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for&nbsp;President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.</p>\n<p><b>'Summer mini-boom'</b></p>\n<p>Before the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a&nbsp;forecast by Treasury Secretary Janet Yellen.</p>\n<p>\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.</p>\n<p>Oxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.</p>\n<p>Likewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"</p>\n<p>\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.</p>\n<p>Indeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.</p>\n<p>The rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.</p>\n<p><b>Double-dip recession averted</b></p>\n<p>The Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.</p>\n<p>For months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.</p>\n<p>At the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.</p>\n<p>\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.</p>\n<p>Slammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States&nbsp;added just 49,000 jobs in January.</p>\n<p>Jobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.</p>\n<p><b>Vaccines to the rescue</b></p>\n<p>But there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.</p>\n<p>Critically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.</p>\n<p>And Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday&nbsp;that the United States may be able to vaccinate most Americans by the middle or end of summer.</p>\n<p>All of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.</p>\n<p>That's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants&nbsp;force US states and cities to once again tighten health restrictions.</p>\n<p><b>Low-wage workers are still hurting badly</b></p>\n<p>Against this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.</p>\n<p>\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"</p>\n<p>Doing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.</p>\n<p>Employment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.</p>\n<p>\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.</p>\n<p>However, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.</p>\n<p>\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.</p>\n<p><b>'Bring it on'</b></p>\n<p>Some economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington&nbsp;overheats the economy by injecting too much support.</p>\n<p>\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.</p>\n<p>And that in turn would spook the&nbsp;red-hot stock market.</p>\n<p>Fed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.</p>\n<p>Citing \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.</p>\n<p>Zandi isn't losing sleep over inflation, mostly because the United States is far from full employment.</p>\n<p>\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With Biden going big, Wall Street economists are growing bullish on the US economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith Biden going big, Wall Street economists are growing bullish on the US economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-16 18:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html><strong>CNN Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://edition.cnn.com/2021/02/11/economy/economy-jobs-biden-stimulus/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108705396","content_text":"New York (CNN Business) The Covid-ravaged American economy was on the verge of slipping into a double-dip recession at the end of 2020. The pandemic was intensifying,gridlock paralyzed Washington and millions of families were about to lose crucial benefits.\nFast forward two months, and the economy is still struggling-- but confidence in the recovery is growing, rapidly.\nEconomists are swiftly upgrading their GDP and unemployment forecasts and pulling forward the date when the Federal Reserve will be able to lift rock-bottom interest rates. Goldman Sachs is predicting the US economy will grow at the fastest clip in more than three decades.\nThe renewed optimism is being driven by two major factors: the health crisis is easing and Uncle Sam is coming to the rescue with staggering amounts of aid-- hundreds of billions more than seemed to be in the cards just months ago.\nAfter supplying $4 trillion of relief last year, Washington is expected to pump in another $2 trillion of deficit-financed support in 2021, according to Moody's Analytics. That represents more than a quarter of annual US GDP.\n\"That is a lot of economic juice,\" Mark Zandi, chief economist at Moody's Analytics, told CNN Business.\nThe turning point happened last month when Democrats took narrow control of the US Senate by sweeping the runoff races in Georgia. That opened a path for President Joe Biden's $1.9 trillion American Rescue Plan, which features $1,400 stimulus checks, enhanced unemployment benefits and a $350 billion lifeline to state and local governments.\n'Summer mini-boom'\nBefore the Georgia elections, Zandi didn't think the US economy would return to full employment (a strong labor market with 4% unemployment) until the spring or summer of 2023. Now, he expects that achievement to happen next spring, echoing a forecast by Treasury Secretary Janet Yellen.\n\"Super-charged fiscal policy\" means the argument for the US economy growing faster than its peers \"seems to get stronger day-by-day,\" economists at Bank of America wrote in a recent report to clients.\nOxford Economics chief US economist Gregory Daco is calling for a \"summer mini-boom\" in the United States and 5.9% GDP growth in 2021.\nLikewise, Jefferies economists say \"explosive income growth (courtesy of fiscal stimulus) is likely to propel US GDP 6.4% higher this year and nearly 5% next year.\"\n\"If anything, our forecast might be too conservative,\" Jefferies told clients in a recent note, pointing out that its view incorporates just $1 trillion of the Biden plan.\nIndeed, Goldman Sachs upgraded its 2021 GDP forecast to 6.8% earlier this week because the Wall Street bank now assumes additional fiscal relief of $1.5 trillion, up from $1.1 trillion previously. If Goldman's prediction comes true, it would be the fastest annual GDP growth for the United States since 1989,according to the St. Louis Fed.\nThe rosy GDP forecasts are well above what the Federal Reserve is calling for. In December, the Fed expected 2021 GDP growth of just 4.2% and said unemployment wouldn't slip below 4% until 2023.\nDouble-dip recession averted\nThe Fed tends to be conservative with its economic forecasts. And, crucially, the Fed forecast was released at a time when political dysfunction in DC was casting a shadow over the US economy.\nFor months, Republicans and Democrats tried and failed to reach a deal on extending crucial unemployment and eviction benefits scheduled to lapse and providing more forgivable loans to small businesses. And then when a deal was finally reached, former President Donald Trump threatened to blow it up.\nAt the last minute, Trump signed the $900 billion relief package into law, averting economic disaster.\n\"Without that, we would be in a double dip recession,\" said Zandi, the Moody's economist.\nSlammed by the pandemic, the US economy limped to the end of 2020 and started this year slowly. In December, employers cut jobs in for the first time since the spring. And the United States added just 49,000 jobs in January.\nJobless claims remain alarmingly high. Another 793,000 Americans filed for first time unemployment benefits last week alone. For context, that is above the worst levels of the Great Recession.\nVaccines to the rescue\nBut there are glimmers of hope on the pandemic. Although Covid deaths remain unthinkably high, hospitalizations and cases have retreated.\nCritically, the rollout of coronavirus vaccines is accelerating. Out of a total of 66 million vaccines distributed, about 70% have been administered, according to Morgan Stanley.\nAnd Dr. Anthony Fauci, the nation's top infectious disease expert,told NBC News Thursday that the United States may be able to vaccinate most Americans by the middle or end of summer.\nAll of this has allowed states including California, New York and New Jersey to relax health restrictions crushing restaurants and other small businesses.\nThat's not to say the pandemic is over. In fact,one risk is that new Covid-19 variants force US states and cities to once again tighten health restrictions.\nLow-wage workers are still hurting badly\nAgainst this backdrop, many economists are urging Washington to push ahead with plans for aggressive fiscal stimulus.\n\"Foot flat on the accelerator, please,\" Zandi, the Moody's economist said. \"Policymaking 101 says err on the side of doing too much, rather than too little.\"\nDoing too little risks worsening America's inequality problem. That's because this recession, more than prior ones, disproportionately hurt low-income workers in hard-hit sectors such as restaurants, childcare and hospitality.\nEmployment levels of low-wage workers (those making less than $27,000 per year) is still down more than 20%, according to the Opportunity Insights Economic tracker. By contrast, employment levels of those making more than $60,000 per year are above pre-crisis levels.\n\"Biden's team is unlikely to break out the champagne over reaching full employment if it isn't evident across income and racial groups,\" economists at Bank of America wrote in a report to clients.\nHowever, Danielle DiMartino Booth, a former Fed official who is now CEO of Quill Intelligence, worries the focus on providing income, instead of investing in infrastructure and reskilling workers, will make the country addicted to stimulus.\n\"The economy is going to turn into this dependent patient, always waiting for the next injection,\" Booth said.\n'Bring it on'\nSome economists, including former Treasury Secretary Larry Summers, have warned there is a risk that Washington overheats the economy by injecting too much support.\n\"You could have quite the inflation scare in the next few months that will test the bond market and the Fed,\" Booth said.\nAnd that in turn would spook the red-hot stock market.\nFed watchers are moving up their timelines for when the central bank will be able to end its emergency policies.\nCiting \"signs of a firmer inflation outlook,\" Goldman Sachs now expects the Fed to start \"tapering\" its asset purchases in early 2022 and to raise interest rates in the first half of 2024.\nZandi isn't losing sleep over inflation, mostly because the United States is far from full employment.\n\"It's a vastly overstated worry,\" he said. \"Bring it on. Our biggest problem for more than a decade has been low inflation. Higher inflation would be a high-class problem to have.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":382914803,"gmtCreate":1613348289502,"gmtModify":1704879952212,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good to know and hope everyone in the world will&nbsp;be vaccinated.","listText":"Good to know and hope everyone in the world will&nbsp;be vaccinated.","text":"Good to know and hope everyone in the world will be vaccinated.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/382914803","repostId":"2111082770","repostType":2,"repost":{"id":"2111082770","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613331277,"share":"https://ttm.financial/m/news/2111082770?lang=&edition=fundamental","pubTime":"2021-02-15 03:34","market":"us","language":"en","title":"Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2111082770","media":"Reuters","summary":"JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in ","content":"<html><body><p>JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.</p><p>   Health maintenance organization <a href=\"https://laohu8.com/S/HMO.AU\">$(HMO.AU)$</a> Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus. </p><p>   The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine. </p><p>   \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.</p><p>   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.</p><p>   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.</p><p>   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.</p><p>   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.  </p><p> (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)</p><p>((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-15 03:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.</p><p>   Health maintenance organization <a href=\"https://laohu8.com/S/HMO.AU\">$(HMO.AU)$</a> Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus. </p><p>   The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine. </p><p>   \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.</p><p>   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.</p><p>   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.</p><p>   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.</p><p>   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.  </p><p> (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)</p><p>((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111082770","content_text":"JERUSALEM, Feb 14 (Reuters) - Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's    vaccine in the country's biggest study to date.   Health maintenance organization $(HMO.AU)$ Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.    The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.    \"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,\" said Ran Balicer, Clalit's chief innovation officer.   He added that the data indicates the Pfizer vaccine, which was developed in partnership with Germany's BioNTech   , is even more effective two weeks or more after the second shot.   Researchers at the Weizmann Institute of Science, who have been tabulating national data, said on Sunday that a sharp decline in hospitalisation and serious illness identified earlier among the first age group to be vaccinated - aged 60 or older - was seen for the first time in those aged 55 and older.   Hospitalisations and serious illness were still rising in younger groups who began vaccinations weeks later.   Israel has been conducting a rapid vaccine rollout and its database offers insights into vaccine effectiveness and at what point countries might attain herd immunity.   (Reporting by Ari Rabinovitch and Maayan Lubell Editing by David Goodman)((ari.rabinovitch@thomsonreuters.com;  +972-2-632-2202; Reuters Messaging: ari.rabinovitch@thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":360769554,"gmtCreate":1613979717278,"gmtModify":1704886384372,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news! ☺️","listText":"Good news! ☺️","text":"Good news! ☺️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/360769554","repostId":"2113875061","repostType":2,"repost":{"id":"2113875061","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613975392,"share":"https://ttm.financial/m/news/2113875061?lang=&edition=fundamental","pubTime":"2021-02-22 14:29","market":"us","language":"en","title":"Vietnam to start COVID-19 vaccinations in March -state media","url":"https://stock-news.laohu8.com/highlight/detail?id=2113875061","media":"Reuters","summary":"HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with fron","content":"<html><body><p>HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.</p><p>   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca</p><p>  vaccine due to arrive on Feb. 28.   </p><p>   \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.</p><p>   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said. </p><p>   The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.</p><p>   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme. </p><p>   Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.  </p><p>   Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.   </p><p>   The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus. </p><p> (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)</p><p>((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vietnam to start COVID-19 vaccinations in March -state media</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVietnam to start COVID-19 vaccinations in March -state media\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-22 14:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.</p><p>   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca</p><p>  vaccine due to arrive on Feb. 28.   </p><p>   \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.</p><p>   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said. </p><p>   The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.</p><p>   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme. </p><p>   Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.  </p><p>   Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.   </p><p>   The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus. </p><p> (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)</p><p>((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2113875061","content_text":"HANOI, Feb 22 (Reuters) - Vietnam will begin its COVID-19 vaccination programme next month with frontline healthcare staff and the elderly in line for the first doses as the country tackles a new wave of coronavirus infections, state media reported on Monday.   The Southeast Asian country expects to receive 60 million doses this year, including 30 million under the WHO-led COVAX scheme, with a first batch of 204,000 doses of the AstraZeneca  vaccine due to arrive on Feb. 28.      \"The first wave of COVID-19 vaccinations, prioritising frontline medical workers and high-risk groups, will begin in March right after the first batch of the AstraZeneca vaccine arrives and passes quality checks,\" the state-run Tuoi Tre newspaper reported.   Refrigerators able to store vaccines at temperatures of -86 to -40 degrees Celsius (-186°F to -104°F) had been prepared in the country's three biggest cities of Hanoi, Ho Chi Minh City and Danang, the paper said.    The government said previously it was in talks with Russian and U.S. vaccine manufacturers on potential supply agreements, while it expects a home-grown vaccine to be ready for domestic inoculation by May.   Vietnam's health ministry did not immediately respond to a request for comment its vaccination programme.    Late last month, Vietnam approved the AstraZeneca vaccine for emergency use days after the country detected the first locally transmitted cases in nearly two months.     Thanks to targeted mass testing and strict quarantining, Vietnam managed to successfully contain the virus for months but a fresh outbreak has proved more difficult to stamp out.      The country of 98 million people has recorded 791 new cases since the latest outbreak started last month, or about a third of its overall caseload of 2,383 infections since cases were first detected a year ago. Vietnam has reported 35 deaths due to the virus.  (Reporting by Phuong Nguyen and Khanh Vu Editing by Ed Davies)((haphuong.nguyen@thomsonreuters.com; +84-24-3852-9623;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":387751023,"gmtCreate":1613789297262,"gmtModify":1704885042375,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good news!&nbsp;","listText":"Good news!&nbsp;","text":"Good news!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/387751023","repostId":"2112493847","repostType":2,"repost":{"id":"2112493847","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613786647,"share":"https://ttm.financial/m/news/2112493847?lang=&edition=fundamental","pubTime":"2021-02-20 10:04","market":"us","language":"en","title":"New Zealand begins COVID-19 vaccinations programme, Australia starts Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2112493847","media":"Reuters","summary":"Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on","content":"<html><body><p>Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.  </p><p>   A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.  </p><p>   In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.</p><p>   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.</p><p>   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"</p><p>   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.</p><p>   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.</p><p>   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.   </p><p>   The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.  </p><p>   Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.</p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)</p><p>((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand begins COVID-19 vaccinations programme, Australia starts Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand begins COVID-19 vaccinations programme, Australia starts Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-20 10:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.  </p><p>   A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.  </p><p>   In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.</p><p>   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.</p><p>   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"</p><p>   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.</p><p>   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.</p><p>   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.   </p><p>   The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.  </p><p>   Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.</p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)</p><p>((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112493847","content_text":"Feb 20 (Reuters) - New Zealand started its official rollout of Pfizer-BioNTech's COVID-19 vaccine on Saturday, while Australia finalised plans to begin inoculations on Monday, a new phase in tackling the virus that both countries have kept largely contained.     A small group of medical professionals were injected on Friday in Auckland ahead of the wider rollout which was officially starting with border staff and so-called Managed Isolation and Quarantine (MIQ) workers on Saturday, officials said.     In Australia, hotel quarantine and healthcare workers will also be the first cohort to be inoculated at 16 Pfizer vaccination hubs across the nation, alongside older Australians at aged care facilities.   \"Today, we kick off the largest immunisation programme in our history, by vaccinating the first of our border workforce, a critical step in protecting everyone in Aotearoa,\" New Zealand health minister Ashley Bloomfield told reporters in Auckland, using the country's indigenous Maori name.   \"We will be moving through these first few days and weeks in a measured way to make sure our systems and processes are solid.\"   New Zealand expects its nationwide rollout covering the country's population of 5 million will take a full year, while Australia aims to inoculate its 25 million citizens by October.   No new COVID-19 infections were reported in the communities of either country in the previous 24 hours despite tens of thousands of tests, officials said.   Both nations ended snap local lockdowns this week after a cluster emerged from a quarantine hotel in Melbourne and as New Zealand authorities investigate how a strain of a highly transmissible UK variant was found in three members of an Auckland family.      The two countries rank among the top 10 globally in a COVID-19 performance index for their successful handling of the pandemic.     Australia has recorded just under 29,000 cases and 909 deaths, while New Zealand has recorded just 26 deaths from 2,350 cases.    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global COVID tracker       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Paulina Duran in Sydney; Editing by Lincoln Feast.)((paulina.duran@thomsonreuters.com; +61 2 9171 7406; Reuters Messaging: paulina.duran.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384561805,"gmtCreate":1613661376107,"gmtModify":1704883422964,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Good read!&nbsp;","listText":"Good read!&nbsp;","text":"Good read!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384561805","repostId":"1102078157","repostType":4,"repost":{"id":"1102078157","pubTimestamp":1613643052,"share":"https://ttm.financial/m/news/1102078157?lang=&edition=fundamental","pubTime":"2021-02-18 18:10","market":"sg","language":"en","title":"Singapore Exchange hopes to list SPACs as early as this year","url":"https://stock-news.laohu8.com/highlight/detail?id=1102078157","media":"Bloomberg","summary":"[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enoug","content":"<p>[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies&nbsp;this year if it gets enough support from the industry.</p><p>An impending marketconsultation on special purpose acquisition companies&nbsp;(SPAC)this quarter could take some time to get feedback, chief executive officer (CEO) Loh Boon Chye said in an interview Wednesday.</p><p>\"If the market is supportive, we hope to be able to do that sometime this year.\"</p><p>SPACs became a buzzword last year, sprouting by the dozen as the rich and famous - from hedge fund billionaire Bill Ackman to former US Speaker of the House Paul Ryan - and private equity firms rushed to set up new ones.</p><p>SPACs are increasingly seen as an appealing alternative route to public markets because the process avoids the risk and uncertainty of an initial public offering, though they've also been criticised for their structure, where managers - the founders - collect fees as an incentive to find a target and complete a deal. Many blank-cheque companies have turned to Asia to seek takeover targets.</p><p>The concept isn't new to the Singapore exchange. It had initiated a consultation on SPAC listings in 2010 - but there wasn't enough appetite among businesses and investors back then.</p><p>\"The world has changed, capital markets have evolved since then,\" said Mr Loh, who took over as CEO in 2015 after a long career in banking. He added that lower-for-longer interest rates, shorter business cycles, volatile markets and stimulus measures are heightening the need for and the ability to seek capital. SPACs could facilitate that while minimising market risk exposure by providing another avenue for investment, he said.</p><p>SPACs could be a way to revive investor interest in Singapore's stock market. The bourse has struggled to attract big-ticket IPOs over the past few years particularly in hot sectors such as technology. While the market volatility of 2020 was a boon, the value of shares traded remained below its five-year average.</p><p>SGX expects stock market listings this year in various sectors including technology, he said, as it awaits the mega IPO of Thai Beverage's brewery unit. The amount raised in first-time share sales in the city-state slumped to US$914 million last year from US$3.4 billion in 2017, according to data compiled by Bloomberg.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Exchange hopes to list SPACs as early as this year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Exchange hopes to list SPACs as early as this year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-18 18:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enough support from the industry.An impending marketconsultation on special purpose acquisition companies...</p>\n\n<a href=\"https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.businesstimes.com.sg/companies-markets/singapore-exchange-hopes-to-list-spacs-as-early-as-this-year","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102078157","content_text":"[SINGAPORE] The Singapore Exchange (SGX)could list blank-cheque companies this year if it gets enough support from the industry.An impending marketconsultation on special purpose acquisition companies (SPAC)this quarter could take some time to get feedback, chief executive officer (CEO) Loh Boon Chye said in an interview Wednesday.\"If the market is supportive, we hope to be able to do that sometime this year.\"SPACs became a buzzword last year, sprouting by the dozen as the rich and famous - from hedge fund billionaire Bill Ackman to former US Speaker of the House Paul Ryan - and private equity firms rushed to set up new ones.SPACs are increasingly seen as an appealing alternative route to public markets because the process avoids the risk and uncertainty of an initial public offering, though they've also been criticised for their structure, where managers - the founders - collect fees as an incentive to find a target and complete a deal. Many blank-cheque companies have turned to Asia to seek takeover targets.The concept isn't new to the Singapore exchange. It had initiated a consultation on SPAC listings in 2010 - but there wasn't enough appetite among businesses and investors back then.\"The world has changed, capital markets have evolved since then,\" said Mr Loh, who took over as CEO in 2015 after a long career in banking. He added that lower-for-longer interest rates, shorter business cycles, volatile markets and stimulus measures are heightening the need for and the ability to seek capital. SPACs could facilitate that while minimising market risk exposure by providing another avenue for investment, he said.SPACs could be a way to revive investor interest in Singapore's stock market. The bourse has struggled to attract big-ticket IPOs over the past few years particularly in hot sectors such as technology. While the market volatility of 2020 was a boon, the value of shares traded remained below its five-year average.SGX expects stock market listings this year in various sectors including technology, he said, as it awaits the mega IPO of Thai Beverage's brewery unit. The amount raised in first-time share sales in the city-state slumped to US$914 million last year from US$3.4 billion in 2017, according to data compiled by Bloomberg.","news_type":1},"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384014003,"gmtCreate":1613584707502,"gmtModify":1704882466585,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Wow good news.","listText":"Wow good news.","text":"Wow good news.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/384014003","repostId":"1109567373","repostType":4,"repost":{"id":"1109567373","pubTimestamp":1613557874,"share":"https://ttm.financial/m/news/1109567373?lang=&edition=fundamental","pubTime":"2021-02-17 18:31","market":"us","language":"en","title":"PayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109567373","media":"Barrons","summary":"Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of ","content":"<p>Investors can’t get enough of&nbsp;PayPal Holdings,pushing its market value past&nbsp;Mastercard‘s.</p>\n<p>Shares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306. PayPal’s market value is now $359 billion.Mastercard‘s equity, meanwhile, was worth $339 billion at recent prices around $341.</p>\n<p>Mastercard (MA) andVisa(V), the two major card-processing networks, have been hurt by a slowdown in payment volumes related to the pandemic, particularly in highly profitable cross-border transactions. Both stocks are down around 4% this year and are largely flat over the past 52 weeks.</p>\n<p>PayPal, on the other hand, got a lift as the pandemic sent shoppers online and fueled a surge in digital payments. The company is also developing new revenue streams, aiming to become a digital payments “super app,” expanding into everything from Bitcoin to in-store QR-codes, international money transfers, and new peer-to-peer (P2P) services.</p>\n<p>PayPal outlined its five-year strategy in a presentation to investors last week. And some analysts were clearly impressed. Lisa Ellis of MoffettNathanson raised her price target on the stock to $350, reflecting a variety of sources of growth.</p>\n<p>Just about every facet of the business may bepoisedto double over the next five years. PayPal expects to have 750 million active accounts by 2025, up from 377 million now. It sees total payments volume expanding at a 25% annualized rate, reaching $2.8 trillion by 2025.&nbsp; Revenues are expected to hit more than $50 billion, up from an estimated $25.6 billion this year.</p>\n<p>PayPal also expects to boost adjusted operating margins from 25% to 28%, and sees earnings per share rising an average 22% a year. It’s planning to generate $40 billion in free cash flow over the next five years, targeting 30% to 40% for share repurchases.</p>\n<p>As Ellis points out, PayPal has several stepping stones to hit those targets. One is a new service called Buy Now Pay Later, an interest-free installment plan for consumer purchases. The service is gaining traction, with $750 million of transaction volume in the fourth quarter.</p>\n<p>Anothergrowth driveris cryptocurrencies. PayPal users can now buy and store Bitcoin and other cryptocurrencies on its app. The company aims to allow crypto to be used as a funding source with the 28 million merchants on its platform, acting as a middleman between consumers and businesses. Bitcoinhit a record$50,000 on Tuesday, up 75% this year, and it appears to be driving greater usage of PayPal, which could ultimately lead to higher average revenue per customer.</p>\n<p>PayPal also aims to use its Venmo P2P service as a platform for consumer-to-business payments. And PayPal is making inroads with brick-and-mortar merchants through QR technology for contactless payments in stores.</p>\n<p>Does all of this warrant a higher market value and a steep premium to Mastercard stock? The card network is actually expected to lift revenue and profits at a faster pace in fiscal 2021, according to Ellis, growing revenue 21.7% versus 19% for PayPal. She also sees Mastercard’s earnings per share rising 33.3% versus 17.5% for PayPal’s.</p>\n<p>But the five-year outlook is clearly more favorable for PayPal, with revenue rising 21% a year, compared with 15% for Mastercard, and earnings compounding at a 22% rate, versus 17% for Mastercard.</p>\n<p>The question is whether PayPal’s valuation is getting too rich. At 67 times estimated 2021 per-share earnings, PayPal stock is trading nearly three times more expensive than the S&amp;P 500’s P/E ratio of 23 times earnings. Mastercard goes for 42 times 2021 earnings.</p>\n<p>Nonetheless, Wall Street can’t seem to catch up with PayPal’s fast-rising stock. The average target for the stock price is $309, less than 2% above the recent level.</p>\n<p>“You have to appreciate the earnings power in the model,” says Wedbush analyst Moshe Katri, who maintained a $300 target on the stock after the presentation last week. “The more they’re able to expand user engagement and get to point where users keep going back and using its products, the more the user fees can go up.”</p>\n<p>Whether that means the stock can keep climbing will depend on how quickly it can turn into the super-app that Wall Street has come to expect.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPayPal Is Now Worth More Than Mastercard. Why It May Extend Its Lead.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 18:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306....</p>\n\n<a href=\"https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PYPL":"PayPal","MA":"万事达"},"source_url":"https://www.barrons.com/articles/paypal-is-now-worth-more-than-mastercard-why-it-may-extend-its-lead-51613506791?mod=hp_DAY_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109567373","content_text":"Investors can’t get enough of PayPal Holdings,pushing its market value past Mastercard‘s.\nShares of PayPal (ticker: PYPL) have rocketed 31% this year, including a 2.7% gain on Tuesday, to around $306. PayPal’s market value is now $359 billion.Mastercard‘s equity, meanwhile, was worth $339 billion at recent prices around $341.\nMastercard (MA) andVisa(V), the two major card-processing networks, have been hurt by a slowdown in payment volumes related to the pandemic, particularly in highly profitable cross-border transactions. Both stocks are down around 4% this year and are largely flat over the past 52 weeks.\nPayPal, on the other hand, got a lift as the pandemic sent shoppers online and fueled a surge in digital payments. The company is also developing new revenue streams, aiming to become a digital payments “super app,” expanding into everything from Bitcoin to in-store QR-codes, international money transfers, and new peer-to-peer (P2P) services.\nPayPal outlined its five-year strategy in a presentation to investors last week. And some analysts were clearly impressed. Lisa Ellis of MoffettNathanson raised her price target on the stock to $350, reflecting a variety of sources of growth.\nJust about every facet of the business may bepoisedto double over the next five years. PayPal expects to have 750 million active accounts by 2025, up from 377 million now. It sees total payments volume expanding at a 25% annualized rate, reaching $2.8 trillion by 2025.  Revenues are expected to hit more than $50 billion, up from an estimated $25.6 billion this year.\nPayPal also expects to boost adjusted operating margins from 25% to 28%, and sees earnings per share rising an average 22% a year. It’s planning to generate $40 billion in free cash flow over the next five years, targeting 30% to 40% for share repurchases.\nAs Ellis points out, PayPal has several stepping stones to hit those targets. One is a new service called Buy Now Pay Later, an interest-free installment plan for consumer purchases. The service is gaining traction, with $750 million of transaction volume in the fourth quarter.\nAnothergrowth driveris cryptocurrencies. PayPal users can now buy and store Bitcoin and other cryptocurrencies on its app. The company aims to allow crypto to be used as a funding source with the 28 million merchants on its platform, acting as a middleman between consumers and businesses. Bitcoinhit a record$50,000 on Tuesday, up 75% this year, and it appears to be driving greater usage of PayPal, which could ultimately lead to higher average revenue per customer.\nPayPal also aims to use its Venmo P2P service as a platform for consumer-to-business payments. And PayPal is making inroads with brick-and-mortar merchants through QR technology for contactless payments in stores.\nDoes all of this warrant a higher market value and a steep premium to Mastercard stock? The card network is actually expected to lift revenue and profits at a faster pace in fiscal 2021, according to Ellis, growing revenue 21.7% versus 19% for PayPal. She also sees Mastercard’s earnings per share rising 33.3% versus 17.5% for PayPal’s.\nBut the five-year outlook is clearly more favorable for PayPal, with revenue rising 21% a year, compared with 15% for Mastercard, and earnings compounding at a 22% rate, versus 17% for Mastercard.\nThe question is whether PayPal’s valuation is getting too rich. At 67 times estimated 2021 per-share earnings, PayPal stock is trading nearly three times more expensive than the S&P 500’s P/E ratio of 23 times earnings. Mastercard goes for 42 times 2021 earnings.\nNonetheless, Wall Street can’t seem to catch up with PayPal’s fast-rising stock. The average target for the stock price is $309, less than 2% above the recent level.\n“You have to appreciate the earnings power in the model,” says Wedbush analyst Moshe Katri, who maintained a $300 target on the stock after the presentation last week. “The more they’re able to expand user engagement and get to point where users keep going back and using its products, the more the user fees can go up.”\nWhether that means the stock can keep climbing will depend on how quickly it can turn into the super-app that Wall Street has come to expect.","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":385849541,"gmtCreate":1613535409083,"gmtModify":1704881734792,"author":{"id":"3575171209981735","authorId":"3575171209981735","authorIdStr":"3575171209981735","name":"Yanski","avatar":"https://static.tigerbbs.com/988bf8668966a80f734d966b33021e2b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575171209981735"},"themes":[],"htmlText":"Is this the reason why apple numbers is decreasing?","listText":"Is this the reason why apple numbers is decreasing?","text":"Is this the reason why apple numbers is decreasing?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/385849541","repostId":"1106575642","repostType":4,"repost":{"id":"1106575642","pubTimestamp":1613532872,"share":"https://ttm.financial/m/news/1106575642?lang=&edition=fundamental","pubTime":"2021-02-17 11:34","market":"us","language":"en","title":"Apple iCar Speculation Continues. How Tech and Auto Analysts See the Car.","url":"https://stock-news.laohu8.com/highlight/detail?id=1106575642","media":"Barrons","summary":"Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese c","content":"<p>Speculation about an all-electric, self-driving car&nbsp;produced by Apple&nbsp;just won’t die.</p>\n<p>Now Japanese car maker&nbsp;Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder of an Apple-branded vehicle. The iCar has resulted in a lot of Wall Street&nbsp;research reports, but few hard numbers about what an&nbsp;Apple(AAPL) entry might mean for the global car business. What’s more, tech and car analysts have slightly different takes on what the Apple car means.</p>\n<p>News of a potential Apple car surfaced in December. Those reports were taken seriously by both tech and car analysts because Apple has had car ambitions stretching back years—and because Apple is huge. The tech giant has a market capitalization roughly equal to the market cap of all car makers on the globe, combined. That includes the most valuable car company on the planet:Tesla(TSLA).</p>\n<p>Hyundai Motor(005380.Korea),Kia Motors(000270.Korea), as well as&nbsp;U.S. EVstart-up&nbsp;Canoo(GOEV), have all been&nbsp;tied&nbsp;to Apple in reports. Nissan is the latest car company to be linked. Nissan stock fell almost 3% Monday after Reuters reported Nissan’s denial it was working with Apple.</p>\n<p>Apple, and the car companies, haven’t commented on Apple’s car plans. Apple wasn’t immediately available to comment on Nissan reports on Tuesday.</p>\n<p>Outside of&nbsp;temporary impacts&nbsp;on car companies directly linked to Apple, car stocks aren’t really reacting to iCar news. Crying wolf is one reason: Nothing concrete has come from repeated speculation. And of course, an Apple car would be years away—another reason auto investors aren’t too concerned for the moment.</p>\n<p>That doesn’t mean an Apple car won’t matter, or that news of potential partnerships can be discounted. Wedbush analyst&nbsp;Dan Ives&nbsp;expects a formal announcement in 2021. “At this point it’s a matter of when, not if,&nbsp;Apple&nbsp;will enter the EV race over the next few years,” wrote Ives in a Monday research report. He assigns an 85% probability that Apple will make an announcement in three to six months and calls Hyundai and&nbsp;Volkswagen(VOW.Germany) his top two choices for an Apple partnership.</p>\n<p>Hyundai has its own&nbsp;modular EV platform. That’s one reason Ives likes Hyundai as a possibility, although other auto makers, including&nbsp;General Motors(GM), have&nbsp;similar approaches&nbsp;to electric-vehicle development. Volkswagen, for its part, has big EV ambitions. It is also a&nbsp;large shareholder&nbsp;of&nbsp;QuantumScape(QS), which is&nbsp;pioneering&nbsp;solid-state, lithium anode EV batteries. Those batteries promise lower cost, better safety, faster charging, and more range. Both things could make Volkswagen attractive to a partner.</p>\n<p>Ives covers mainly technology stocks. He covers Apple, rating shares outperform and has a $175 price target for shares. He also covers Telsa stock, rating shares Hold with a $950 price target for shares. Bernstein analyst&nbsp;Toni Sacconaghi, covers both as well. He rates Apple stock Hold and has a $132 price target for shares. He is more bearish on Tesla though. He believes an Apple car would make it harder for Tesla to meet its volume growth goal of 50% a year on average for the next few years. “The automotive market has historically been highly fragmented, with strong regional brands and preferences,” wrote Sacconaghi in a recent research report. “It is uncertain to us that amid massive new competition and entry, the market will ultimately become more consolidated and/or have one outsized winner.”</p>\n<p>That’s bad news for Tesla in his mind. He rates Tesla shares Sell and has a $180 price target for the stock, well below where shares are trading.</p>\n<p>Morgan Stanley analyst&nbsp;Adam Jonas&nbsp;covers cars and not Apple. But he is bullish on Tesla stock, rating shares Buy with an $880 price target. An Apple car entry could speed EV penetration, which would benefit all EV makers. In addition, Tesla “can iterate industry-leading battery technology for another four or five years before Apple may be on the scene,” wrote Jonas in a recent research report. “But at some point, today’s EV players must share the sandbox.”</p>\n<p>More EV players, however, aren’t enough to shake his confidence in Tesla stock. In addition to Tesla, Jonas recommends stock in GM and supplier&nbsp;Aptiv(APTV) to get exposure to the&nbsp;EV theme.</p>\n<p>RBC analyst Joe Spak also covers car stocks. He, like Jonas, rates GM and Aptiv stock Buy but rates Tesla stock Hold. The emergence of an Apple car, for Spak, highlights the need for car makers to adapt at faster rates. “Otherwise they could get left behind, whether it’s by Apple or someone else,” wrote Spak in a recent research report.</p>\n<p>Overall, Wall Street appears to believe few things about the iCar: It will be a premium self-driving product, and will be built by an existing auto maker. It is good news for Apple stock, but it might not be that disruptive to the existing industry—initial volumes will be small, and it will boost consumer interest in EVs. What’s more, news of an Apple car will drive incumbents to improve. Time will tell if that turns out to be how the industry develops.</p>\n<p>Apple car news, again, doesn’t appear to be hitting stocks all that much. Tesla stock is down 2.4% on Tuesday. Apple stock is down 1.6%. The&nbsp;S&amp;P 500,for comparison, is down about 0.1% and the&nbsp;Dow Jones Industrial Average&nbsp;is up about 0.2%.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple iCar Speculation Continues. How Tech and Auto Analysts See the Car.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple iCar Speculation Continues. How Tech and Auto Analysts See the Car.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 11:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese car maker Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AAPL":"苹果","GM":"通用汽车"},"source_url":"https://www.barrons.com/articles/apple-icar-ev-speculation-nissan-tesla-51613492754?mod=hp_LEAD_4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1106575642","content_text":"Speculation about an all-electric, self-driving car produced by Apple just won’t die.\nNow Japanese car maker Nissan Motor(ticker: 7201.Japan) has denied reports that it is in talks to be the builder of an Apple-branded vehicle. The iCar has resulted in a lot of Wall Street research reports, but few hard numbers about what an Apple(AAPL) entry might mean for the global car business. What’s more, tech and car analysts have slightly different takes on what the Apple car means.\nNews of a potential Apple car surfaced in December. Those reports were taken seriously by both tech and car analysts because Apple has had car ambitions stretching back years—and because Apple is huge. The tech giant has a market capitalization roughly equal to the market cap of all car makers on the globe, combined. That includes the most valuable car company on the planet:Tesla(TSLA).\nHyundai Motor(005380.Korea),Kia Motors(000270.Korea), as well as U.S. EVstart-up Canoo(GOEV), have all been tied to Apple in reports. Nissan is the latest car company to be linked. Nissan stock fell almost 3% Monday after Reuters reported Nissan’s denial it was working with Apple.\nApple, and the car companies, haven’t commented on Apple’s car plans. Apple wasn’t immediately available to comment on Nissan reports on Tuesday.\nOutside of temporary impacts on car companies directly linked to Apple, car stocks aren’t really reacting to iCar news. Crying wolf is one reason: Nothing concrete has come from repeated speculation. And of course, an Apple car would be years away—another reason auto investors aren’t too concerned for the moment.\nThat doesn’t mean an Apple car won’t matter, or that news of potential partnerships can be discounted. Wedbush analyst Dan Ives expects a formal announcement in 2021. “At this point it’s a matter of when, not if, Apple will enter the EV race over the next few years,” wrote Ives in a Monday research report. He assigns an 85% probability that Apple will make an announcement in three to six months and calls Hyundai and Volkswagen(VOW.Germany) his top two choices for an Apple partnership.\nHyundai has its own modular EV platform. That’s one reason Ives likes Hyundai as a possibility, although other auto makers, including General Motors(GM), have similar approaches to electric-vehicle development. Volkswagen, for its part, has big EV ambitions. It is also a large shareholder of QuantumScape(QS), which is pioneering solid-state, lithium anode EV batteries. Those batteries promise lower cost, better safety, faster charging, and more range. Both things could make Volkswagen attractive to a partner.\nIves covers mainly technology stocks. He covers Apple, rating shares outperform and has a $175 price target for shares. He also covers Telsa stock, rating shares Hold with a $950 price target for shares. Bernstein analyst Toni Sacconaghi, covers both as well. He rates Apple stock Hold and has a $132 price target for shares. He is more bearish on Tesla though. He believes an Apple car would make it harder for Tesla to meet its volume growth goal of 50% a year on average for the next few years. “The automotive market has historically been highly fragmented, with strong regional brands and preferences,” wrote Sacconaghi in a recent research report. “It is uncertain to us that amid massive new competition and entry, the market will ultimately become more consolidated and/or have one outsized winner.”\nThat’s bad news for Tesla in his mind. He rates Tesla shares Sell and has a $180 price target for the stock, well below where shares are trading.\nMorgan Stanley analyst Adam Jonas covers cars and not Apple. But he is bullish on Tesla stock, rating shares Buy with an $880 price target. An Apple car entry could speed EV penetration, which would benefit all EV makers. In addition, Tesla “can iterate industry-leading battery technology for another four or five years before Apple may be on the scene,” wrote Jonas in a recent research report. “But at some point, today’s EV players must share the sandbox.”\nMore EV players, however, aren’t enough to shake his confidence in Tesla stock. In addition to Tesla, Jonas recommends stock in GM and supplier Aptiv(APTV) to get exposure to the EV theme.\nRBC analyst Joe Spak also covers car stocks. He, like Jonas, rates GM and Aptiv stock Buy but rates Tesla stock Hold. The emergence of an Apple car, for Spak, highlights the need for car makers to adapt at faster rates. “Otherwise they could get left behind, whether it’s by Apple or someone else,” wrote Spak in a recent research report.\nOverall, Wall Street appears to believe few things about the iCar: It will be a premium self-driving product, and will be built by an existing auto maker. It is good news for Apple stock, but it might not be that disruptive to the existing industry—initial volumes will be small, and it will boost consumer interest in EVs. What’s more, news of an Apple car will drive incumbents to improve. Time will tell if that turns out to be how the industry develops.\nApple car news, again, doesn’t appear to be hitting stocks all that much. Tesla stock is down 2.4% on Tuesday. Apple stock is down 1.6%. The S&P 500,for comparison, is down about 0.1% and the Dow Jones Industrial Average is up about 0.2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}